|

Clinical Trials in New York

2,640 recruiting studies across 1 city, spanning 17 conditions.

Browse by Condition

Alzheimer's DiseaseAnxietyArthritisAsthmaBreast CancerCancerCOPDDepressionDiabetesHeart DiseaseLiver CancerLiver DiseaseLung CancerLupusMultiple SclerosisParkinson's DiseaseWeight Loss

Browse by City

New York
2640 trials

All Trials in New York

Phase
Trial Phase Dist.
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLPhase 2<1 mi
E-Mindfulness Approaches for Living After Breast CancerPhase 3<1 mi
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN StudyPhase 2/3<1 mi
Colon Adjuvant Chemotherapy Based on Evaluation of Residual DiseasePhase 2/3<1 mi
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI TrialPhase 2<1 mi
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment TrialPhase 2<1 mi
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyPhase 3<1 mi
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus PembrolizumabPhase 3<1 mi
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast CancerPhase 3<1 mi
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25Phase 3<1 mi
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialPhase 2<1 mi
Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung CancerPhase 3<1 mi
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung CancerPhase 3<1 mi
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung CancerPhase 2/3<1 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerPhase 1/2<1 mi
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group StudyPhase 1/2<1 mi
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2<1 mi
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabPhase 3<1 mi
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive MeningiomasPhase 2<1 mi
Project: Every Child for Younger Patients With Cancer—<1 mi
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by SurgeryPhase 3<1 mi
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative RhabdomyosarcomaPhase 3<1 mi
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)Phase 3<1 mi
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)Phase 3<1 mi
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLyPhase 3<1 mi
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell TumorsPhase 3<1 mi
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal SarcomaPhase 3<1 mi
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant DepressionN/A<1 mi
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE—<1 mi
Pivotal Study for the Cardiac Performance System (CPS)—<1 mi
Anticoagulation in ICH Survivors for Stroke Prevention and RecoveryPhase 3<1 mi
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart FailureN/A<1 mi
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABGPhase 3<1 mi
PROGRESS: Management of Moderate Aortic Stenosis by Clinical Surveillance or TAVRN/A<1 mi
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.N/A<1 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—<1 mi
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerPhase 3<1 mi
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung CancerPhase 3<1 mi
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung CancerPhase 3<1 mi
Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the BrainPhase 3<1 mi
Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck CancerPhase 2/3<1 mi
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian CancerPhase 3<1 mi
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney CancerPhase 3<1 mi
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular EventsPhase 3<1 mi
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the HeartPhase 3<1 mi
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailurePhase 3<1 mi
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers—<1 mi
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval StudyN/A<1 mi
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection—<1 mi
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)Phase 3<1 mi
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)Phase 3<1 mi
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary DiseasePhase 3<1 mi
A Study to Assess the Efficacy, Safety and Tolerability of VLS-01 Buccal Film, Compared to Placebo in Patients With Treatment Resistant Depression (ELUMINA)Phase 2<1 mi
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products—<1 mi
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection FractionPhase 3<1 mi
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With DapagliflozinPhase 3<1 mi
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)Phase 2<1 mi
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone SurgeryPhase 2<1 mi
Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerPhase 3<1 mi
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic CancerPhase 1/2<1 mi
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)Phase 2<1 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial DiseasePhase 2<1 mi
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal CancerPhase 4<1 mi
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors—<1 mi
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric CancerPhase 3<1 mi
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian CancerN/A<1 mi
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical CancerPhase 3<1 mi
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)Phase 3<1 mi
Testing the Addition of Radiation Therapy to the Usual Immune Therapy Treatment (Atezolizumab) for Extensive Stage Small Cell Lung Cancer, The RAPTOR TrialPhase 2/3<1 mi
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast CancerPhase 3<1 mi
Copper Cu 64 PSMA I&T PET Imaging in Men With Newly Diagnosed Prostate CancerPhase 3<1 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)Phase 3<1 mi
"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"Phase 3<1 mi
Study to Evaluate the Efficacy and Safety of VQW-765 for the On-Demand Treatment of Social Anxiety DisorderPhase 3<1 mi
A Study of Revumenib and Mezigdomide in People With LeukemiaPhase 1/2<1 mi
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell CarcinomaPhase 2<1 mi
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER StudyPhase 3<1 mi
A Study of Ivonescimab in People With Endometrial and Cervical CancersPhase 2<1 mi
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell CancerPhase 1/2<1 mi
Impact of ICCAN on Cancer Treatment Completion and Quality of Life—<1 mi
A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal CancersPhase 2<1 mi
A Study Comparing Two Optical Coherence Tomography Devices in People With Ocular TumorsN/A<1 mi
Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive SurgeryPhase 2<1 mi
A Study of Magnetic Resonance Imaging of the Pancreas for Cancer Screening—<1 mi
ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial CancerN/A<1 mi
Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer—<1 mi
Kidney Cancer DNA Registry—<1 mi
Ulixertinib in People With Histiocytic NeoplasmsPhase 2<1 mi
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur StudyPhase 3<1 mi
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal CancerPhase 3<1 mi
A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian CancerPhase 2<1 mi
FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor CancersPhase 1<1 mi
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)Phase 1<1 mi
Hyperpolarized C Pyruvate Magnetic Resonance Imaging, and Blood-Based Biomarkers for Early Detection of Pancreatic Adenocarcinoma in Patients With Intraductal Papillary Mucinous Neoplasms—<1 mi
A Study of Avutometinib (VS-6766) and Defactinib in People With Mesonephric Gynecologic CancerPhase 2<1 mi
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat CancerPhase 2<1 mi
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)N/A<1 mi
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)Phase 2<1 mi
A Study of Changes to Prostate ProceduresPhase 3<1 mi
A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell TransplantPhase 2<1 mi
Using a Blood Test and Software Tool to Guide Treatment for Venous ThromboembolismN/A<1 mi
A Study of the Use of 3D Technology to Guide Head and Neck SurgeryN/A<1 mi
A Study of Herbal Supplements in Cancer Survivors With ConstipationN/A<1 mi
A Study of Pembrolizumab Plus Local Chemotherapy Using Isolated Limb Infusion (ILI) for Patients With Sarcoma in the Arm or LegPhase 2<1 mi
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin LymphomaPhase 2<1 mi
A Study of Ivonescimab in People With LeiomyosarcomaPhase 2<1 mi
A Study of Reduced Dose Radiation Therapy for People With B-Cell LymphomasPhase 3<1 mi
A Study of Cardiac Magnetic Resonance Imaging (CMR) for Evaluating Catheter-Associated Right Atrial Clot in People With CancerN/A<1 mi
A Study of Abemaciclib and Cabozantinib in People With Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1/2<1 mi
A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic LeukemiaPhase 2<1 mi
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With GlioblastomaPhase 1<1 mi
A Study of Selinexor in People With Wilms Tumors and Other Solid TumorsPhase 2<1 mi
A Study Comparing Standard Treatments in People With Non-Muscle Invasive Bladder Cancer (NMIBC)Phase 3<1 mi
A Study of Intra-operative Imaging in Women With Ovarian CancerPhase 3<1 mi
Enfortumab Vedotin and Pembrolizumab in People With Bladder CancerPhase 2<1 mi
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas—<1 mi
Study of 2141-V11 in People With Non-muscle Invasive Bladder Cancer That Did Not Respond to Standard TreatmentPhase 1<1 mi
A Study of Botensilimab and Balstilimab for Rectal AdenocarcinomaPhase 2<1 mi
A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid LeukemiaPhase 2<1 mi
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL TrialPhase 3<1 mi
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)Phase 2<1 mi
Study of a Support Program for Quality of Life in Chinese Cancer Patients and SurvivorsN/A<1 mi
Registry Study of People Who Are Having an Esophagectomy and Are at High Risk of Anastomotic Leak—<1 mi
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome PatientsPhase 2<1 mi
Genomic Profiling in Cancer Patients—<1 mi
Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromesPhase 1<1 mi
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate CancerPhase 2<1 mi
Reflectance Confocal Microscopy of Oral Cancers in Vivo: a Preliminary Trial Comparing Intra-oral Imaging With Pathology—<1 mi
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple MyelomaPhase 1/2<1 mi
A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary TractPhase 2<1 mi
Comparing Proton Therapy to Photon Radiation Therapy for Esophageal CancerPhase 3<1 mi
A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)Phase 2<1 mi
Study of Ruxolitinib in Relapsed or Refractory T or NK Cell LymphomaPhase 2<1 mi
A Study of Radiation Therapy After Surgery in People With Oral Tongue Squamous Cell CarcinomaPhase 2<1 mi
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic ChangePhase 2<1 mi
A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck CancerPhase 1<1 mi
A Study of Questionnaires in Adolescents and Young Adults With Cancer—<1 mi
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat CancerPhase 2<1 mi
A Dietary Study for People With Multiple MyelomaN/A<1 mi
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical CancerPhase 2<1 mi
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)Phase 2<1 mi
A Music Therapy Study for Blood Cancer Survivors With Cognitive DifficultiesN/A<1 mi
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialPhase 2<1 mi
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE TrialPhase 3<1 mi
Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell LymphomaEarly 1<1 mi
Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive SurgeryPhase 2<1 mi
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy—<1 mi
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease—<1 mi
A Study of Gefitinib, Trametinib, Disulfiram, and Sunitinib in Addition to Standard Chemotherapy in People With OsteosarcomaPhase 2<1 mi
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following TreatmentPhase 2<1 mi
A Study of Neurocognitive Tests and Questionnaires for People With Head and Neck Cancer Who Are Undergoing Radiation Therapy—<1 mi
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell TransplantPhase 2<1 mi
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain CancerPhase 3<1 mi
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and HypogammaglobulinemiaPhase 2<1 mi
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate CancerPhase 3<1 mi
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal CavityPhase 2/3<1 mi
A Study of ASTX727 in People With Malignant Peripheral Nerve Sheath Tumors (MPNST)Phase 2<1 mi
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate CancerN/A<1 mi
Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid TumorsPhase 2<1 mi
Collecting Information About Treatment Results for Patients With Cushing's Syndrome—<1 mi
A Study of ELI-002 7P, With or Without Tislelizumab, in People With Pancreatic CancerPhase 1<1 mi
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic LymphomaPhase 2<1 mi
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)Phase 2<1 mi
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for TransplantPhase 3<1 mi
A Study of Response to Standard Treatment Before Surgery in People With Rectal CancerN/A<1 mi
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal CancerPhase 3<1 mi
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG TherapyPhase 3<1 mi
A Study of Lower Dose Radiation Therapy for People With Prostate CancerPhase 2<1 mi
Groningen International Study on Sentinel Nodes in Vulvar Cancer-IIIPhase 2<1 mi
A Study of Multiparametric Ultrasound Imaging MethodsN/A<1 mi
A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)Phase 1<1 mi
Collection of Information to Better Understand Young Onset Colorectal Cancer—<1 mi
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)Phase 2<1 mi
Glioma Developmental and HyperActive Ras Tumor (DHART) Board—<1 mi
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck CancerPhase 2<1 mi
A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular LymphomaPhase 2<1 mi
A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell CarcinomaPhase 2<1 mi
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate CancerPhase 1/2<1 mi
A Study of Multiparametric Ultrasound Imaging (mpUS) for People With Endometrial CancerN/A<1 mi
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin CancerPhase 1<1 mi
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.Phase 3<1 mi
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous TreatmentPhase 3<1 mi
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With CancerN/A<1 mi
A Study of Deferoxamine (DFO) in People With Leptomeningeal MetastasisPhase 1<1 mi
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell LymphomaPhase 2<1 mi
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and ChemotherapyPhase 2<1 mi
Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of 177Lu-PSMA-617 in People With GliomasPhase 1<1 mi
A Study Testing Topical Pain-Relieving Herbal Plasters in People Who Are Using Opioids for Their PainPhase 1<1 mi
A Study of Mirdametinib in People With Central Nervous System TumorsPhase 1/2<1 mi
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)Phase 2<1 mi
A Study of Sotorasib in People With Brain TumorsPhase 1<1 mi
A Study of CRD3874-SI in People With Solid TumorsPhase 1<1 mi
A Study of Pembrolizumab in People With Ultra-Rare SarcomasPhase 2<1 mi
A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)N/A<1 mi
Normative Ranges of Lingual Strength and Endurance and the Impact of the IOPI Lingual Strength Trainer on Quantitative Functional Outcomes and Patient-Reported Outcomes After Partial Glossectomy or Hemiglossectomy for Oral Tongue Cancer, An Unblinded: Randomized Pilot StudyN/A<1 mi
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 MutationPhase 2<1 mi
A Study of SER-155 to Treat Diarrhea in People on ImmunotherapyPhase 1<1 mi
A Study of Mirdametinib in Combination With Palbociclib in People With LiposarcomaPhase 1/2<1 mi
A Study Evaluating the Use of an Indoor Air Quality Monitor to Promote a Smoke-free HomeN/A<1 mi
A Study of Meaning-Centered Psychotherapy for Caregivers to People With CancerN/A<1 mi
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial CancerPhase 3<1 mi
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)Phase 1<1 mi
A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerPhase 1<1 mi
A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1Phase 2<1 mi
A Study of Teclistamab and Mezigdomide in People With Multiple MyelomaPhase 1<1 mi
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity CancerPhase 2/3<1 mi
A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Elacestrant Alone or in Combination With Abemaciclib in People With Endometrial CancerPhase 2<1 mi
Germ Cell Tumor and Testicular Tumor DNA Registry—<1 mi
A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor CancerPhase 1<1 mi
A Study of Isoquercetin in People With Ovarian CancerPhase 2<1 mi
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)N/A<1 mi
A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell TransplantPhase 2<1 mi
A Study of Pasireotide in People With ProlactinomaPhase 2<1 mi
A Study of ADCLEC.syn1 in People With Acute Myeloid LeukemiaPhase 1<1 mi
Acupuncture for People Experiencing Period Loss Due to ChemotherapyPhase 2<1 mi
A Study of Tucatinib and Trastuzumab in People With Rectal CancerPhase 2<1 mi
Discovering New Genetic Markers in Adults and Children Who May Be At Risk for Hereditary Forms of Cancer—<1 mi
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune SystemPhase 2<1 mi
Post-op T-DM1 in HER-2+ Salivary Gland CarcinomasPhase 2<1 mi
A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL)Phase 1<1 mi
Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryPhase 2<1 mi
A Study Collecting Health Information to Understand and Prevent Gastric Cancer—<1 mi
A Study of Neuropathy Caused by Enfortumab Vedotin in People With Urothelial Carcinoma—<1 mi
A Study of Enfortumab Vedotin in People With Adenoid Cystic CarcinomaPhase 2<1 mi
Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With SurgeryPhase 2<1 mi
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell TherapyPhase 2<1 mi
A Study of Opportunistic Salpingectomy to Prevent Ovarian CancerN/A<1 mi
A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric CancerPhase 2<1 mi
Pembrolizumab, Olaparib, and Temozolomide for People With GliomaPhase 2<1 mi
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment—<1 mi
A Study of BV-AVD in People With Bulky Hodgkin LymphomaPhase 2<1 mi
A Study of CRD3874-SI in People With LeukemiaPhase 1<1 mi
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2Phase 2<1 mi
Novel Biochemical and Molecular Determinants for Soft Tissue Sarcoma—<1 mi
A Study of Tarlatamab for People With Prostate CancerPhase 2<1 mi
A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell TransplantPhase 2<1 mi
A Study of the Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDACPhase 2<1 mi
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL AmyloidosisPhase 3<1 mi
A Study of Cadonilimab Combined With Chemotherapy in People With Gastric or Gastroesophageal Junction CancerPhase 2<1 mi
A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial CancerEarly 1<1 mi
A Study Comparing Personalized Radiation Therapy With Standard Radiation Therapy in People With HPV-Positive Throat CancerPhase 3<1 mi
A Study of Elranatamab and Cyclophosphamide in People With Multiple MyelomaPhase 2<1 mi
A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)Phase 1<1 mi
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test ResultsN/A<1 mi
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic CancerPhase 3<1 mi
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary TumorsPhase 2<1 mi
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders—<1 mi
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous LeukemiaPhase 1<1 mi
A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)Phase 1<1 mi
A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)Phase 1<1 mi
A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma—<1 mi
A Study of Avutometinib and Defactinib in People With Thyroid CancerPhase 2<1 mi
Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland CancersPhase 2<1 mi
A Study of a Vaccine in Combination With Beta-glucan in People With NeuroblastomaPhase 2<1 mi
A Study of Surgical Techniques During CystectomyPhase 3<1 mi
A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)Phase 2<1 mi
A Study of Ruxolitinib and Duvelisib in People With LymphomaPhase 1<1 mi
DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With CancerN/A<1 mi
A Study of a Weight Loss Intervention in People With Endometrial CancerEarly 1<1 mi
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their CaregiversN/A<1 mi
Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With SarcomaN/A<1 mi
Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) ProtocolPhase 4<1 mi
A Study of a One-Time Counseling Session to Help Reduce Depression, Anxiety, and Distress in People With Breast CancerN/A<1 mi
A Study of Revaree Plus in People With Breast CancerPhase 4<1 mi
Talking to Employers and Medical Staff About Breast Cancer Treatment and Your JobN/A<1 mi
A Study of a Decision Tool for People Considering Breast Reconstruction SurgeryN/A<1 mi
A Study of Pembrolizumab and Cryoablation in People With Breast CancerPhase 1<1 mi
HERizon-Breast: A ctDNA-Guided Adaptive Study of Sequential Anti-HER2 Therapies and CNS Prophylaxis to Induce Long-Term RemissionPhase 2<1 mi
Factors Associated With Breast Cancer Risks and Outcomes—<1 mi
A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast CancerPhase 2<1 mi
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander PlacementPhase 4<1 mi
A Registry for People With T-cell Lymphoma—<1 mi
Observational Study of Bone Complications in People With Post-menopausal Breast Cancer Who Have Stopped Treatment With Denosumab and Aromatase Inhibitors—<1 mi
A Study of Blood Pressure Control During Cancer TreatmentPhase 2<1 mi
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell LymphomaPhase 2<1 mi
Study of Aerobic Training for People Receiving Treatment for Breast CancerPhase 2<1 mi
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations—<1 mi
A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast CancerPhase 2<1 mi
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized TrialN/A<1 mi
A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast CancerPhase 3<1 mi
A Study of Abemaciclib and Radiation Therapy in People With Metastatic Breast CancerPhase 1<1 mi
A Study of SDX-7320 in Combination With Eribulin for People With Breast CancerPhase 2<1 mi
A Study to Prevent and Improve Sexual Health Concerns for People With Breast CancerN/A<1 mi
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer SurvivorsPhase 2<1 mi
A Study of Changes in Thinking Related to Aging and Cancer in Breast Cancer Survivors (TRAC)—<1 mi
Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain ControlPhase 3<1 mi
A Study of Surgery and Radiotherapy in People With Breast CancerPhase 2<1 mi
A Study of Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric CancerPhase 1<1 mi
A Study of Language Interpretation Solutions for People With Breast CancerN/A<1 mi
Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma—<1 mi
A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast CancerPhase 1/2<1 mi
A Study of the Impact of Endocrine Therapy on Surgical Outcomes in People With Lobular Breast CancerPhase 2<1 mi
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerPhase 2<1 mi
A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast CancerPhase 2<1 mi
Lymphedema Surveillance Study—<1 mi
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast CancerPhase 1/2<1 mi
A Study of an Alternative Treatment Approach (Preoperative Radiotherapy, Then Mastectomy, Then Immediate Reconstruction Surgery) in People With T4 Breast CancerPhase 1<1 mi
A Study of ZEN003694 in People With Squamous Cell Lung CancerPhase 2<1 mi
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL ActivityPhase 2<1 mi
A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and ChestPhase 2<1 mi
A Study of Lung Cancer Risk—<1 mi
A Study of a Side Effects and Resource Navigation Program for People With CancerN/A<1 mi
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung DiseasePhase 2<1 mi
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung CancerPhase 1<1 mi
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung CancerPhase 1/2<1 mi
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseasePhase 2<1 mi
Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With SurgeryPhase 2<1 mi
A Study of a New PET Scanner in People With Cancer—<1 mi
A Study of Sacituzumab Govitecan in People With MesotheliomaPhase 2<1 mi
Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural MesotheliomaN/A<1 mi
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer—<1 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1Phase 3<1 mi
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the BrainPhase 2<1 mi
A Study of Sotorasib in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung CancerPhase 1/2<1 mi
Using Urine Samples to Identify Lung Cancer—<1 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)Phase 2<1 mi
A Study of Ivonescimab in People With Non-Small Cell Lung CancerPhase 1/2<1 mi
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid TumorsPhase 1<1 mi
A Study of Lung Cancer Screening in People With Unexplained Weight Loss—<1 mi
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM TrialPhase 3<1 mi
A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the BrainPhase 2<1 mi
A Study of Valemetostat in Combination With Atezolizumab in People With Lung CancerPhase 1<1 mi
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.Phase 1<1 mi
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung CancersPhase 2<1 mi
A Study of Hospital-at-Home for People Receiving TarlatamabN/A<1 mi
Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung CancerPhase 1/2<1 mi
A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal MesotheliomaPhase 2<1 mi
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueN/A<1 mi
A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)Phase 3<1 mi
A Registry for People With Lung Cancer—<1 mi
A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung CancerPhase 1<1 mi
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung CancerPhase 2<1 mi
A Study of Lorlatinib in Combination With Ramucirumab in People With Lung CancerPhase 1/2<1 mi
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal CancerPhase 2<1 mi
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical CarcinomaPhase 2<1 mi
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP TrialPhase 3<1 mi
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received ChemotherapyPhase 3<1 mi
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T CellsPhase 2/3<1 mi
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCLPhase 2<1 mi
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple MyelomaPhase 3<1 mi
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2Phase 3<1 mi
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal CancerPhase 3<1 mi
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)Phase 3<1 mi
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary TractPhase 3<1 mi
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate CancerPhase 1<1 mi
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate CancerPhase 3<1 mi
A Phase Ⅰ/Ⅱa Study of HMPL-A251 in Participants With Advanced or Metastatic HER2-expressing Solid TumorsPhase 1/2<1 mi
A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaPhase 3<1 mi
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple MyelomaPhase 3<1 mi
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune DiseasePhase 1<1 mi
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast CancerPhase 3<1 mi
SLV-154 Treatment of Metastatic Solid TumorsPhase 1<1 mi
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerPhase 2<1 mi
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)Phase 3<1 mi
A First-in-Human Study of MEN2312 in Adults With Advanced Breast CancerPhase 1<1 mi
A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03)Phase 1/2<1 mi
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation—<1 mi
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid TumorsPhase 1<1 mi
Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsPhase 1<1 mi
Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 2<1 mi
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-NaïvePhase 1/2<1 mi
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPCPhase 3<1 mi
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET ImagingPhase 3<1 mi
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.N/A<1 mi
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical CancerPhase 4<1 mi
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering MyelomaPhase 3<1 mi
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA MutationPhase 3<1 mi
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients—<1 mi
Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid TumorsPhase 1<1 mi
Enteral Anastomosis for the Treatment of Gastric Outlet Obstruction: A Randomized Controlled Study Comparing Endoscopic Versus Surgical GastrojejunostomyN/A<1 mi
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIPhase 2<1 mi
A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Phase 1<1 mi
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid TumorsPhase 1/2<1 mi
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHLPhase 2<1 mi
A Study of a New Way to Treat Children and Young Adults With a Brain Tumor Called NGGCTPhase 2<1 mi
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)Phase 3<1 mi
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)—<1 mi
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)Phase 3<1 mi
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)Phase 1/2<1 mi
Study of R289 in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS)Phase 1/2<1 mi
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)Phase 1/2<1 mi
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck CancerPhase 3<1 mi
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder CancerPhase 3<1 mi
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)Phase 3<1 mi
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaPhase 2/3<1 mi
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged LeukemiaPhase 2<1 mi
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)Phase 2<1 mi
The Radiation Oncology-Biology Integration Network (ROBIN) Molecular Characterization Trial (MCT) of Standard Short Course Radiotherapy for Rectal CancerN/A<1 mi
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous TreatmentPhase 1/2<1 mi
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 AlterationsPhase 1/2<1 mi
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )Phase 1<1 mi
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)Phase 3<1 mi
Study of Intravenously (IV) Infused Etentamig in Combination With an Oral Cereblon E3 Ligase Modulatory Drug (CELMoD) Agent Assessing Adverse Events and Change in Disease Activity in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
Fabry Disease Registry & Pregnancy Sub-registry—<1 mi
Study of GB-4362 With Enfortumab Vedotin and Pembrolizumab for Advanced Urothelial CancerPhase 1<1 mi
A Trial of Durvalumab (MEDI4736) Plus Monalizumab in Non-Muscle-Invasive Bladder CancerPhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)Phase 3<1 mi
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AMLPhase 1<1 mi
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell MalignanciesPhase 1/2<1 mi
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma PatientsPhase 3<1 mi
A Study of Tagraxofusp in Combination With Venetoclax and Azacitidine in Adults With Untreated CD123+ Acute Myeloid Leukemia Who Cannot Undergo Intensive ChemotherapyPhase 2<1 mi
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)Phase 1/2<1 mi
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 MutationsPhase 3<1 mi
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT TrialPhase 2<1 mi
A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System LymphomaPhase 2<1 mi
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk NeuroblastomaPhase 3<1 mi
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)Phase 1/2<1 mi
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTPhase 2<1 mi
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
A Phase 2 Study of ACR-368 in Endometrial AdenocarcinomaPhase 2<1 mi
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic LeukemiaPhase 2<1 mi
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal CancerPhase 3<1 mi
Testing of Bevacizumab, Erlotinib, and Atezolizumab in Combination for Advanced-Stage Kidney CancerPhase 2<1 mi
Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma PatientsPhase 3<1 mi
A Long-term Study for Participants Previously Treated With Ciltacabtagene AutoleucelPhase 4<1 mi
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)Phase 2<1 mi
Study to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body—<1 mi
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing LossPhase 3<1 mi
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received TreatmentPhase 1/2<1 mi
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract CancerPhase 3<1 mi
A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal CancerPhase 2<1 mi
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto—<1 mi
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AMLPhase 3<1 mi
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic CancerPhase 1<1 mi
Single vs Multi-Dose Insulin for Glycemic Control (SUGAR)N/A<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS GerminomaPhase 2<1 mi
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)N/A<1 mi
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and FatiguePhase 2/3<1 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular EventsN/A<1 mi
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantPhase 3<1 mi
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™N/A<1 mi
ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart ValveN/A<1 mi
Abatacept in Immune Checkpoint Inhibitor MyocarditisPhase 3<1 mi
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical TrialN/A<1 mi
Abbott Structural Heart Device Registry—<1 mi
The ENCIRCLE TrialN/A<1 mi
A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial FibrillationN/A<1 mi
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic ValvesN/A<1 mi
Individualizing Treatment for Asthma in Primary Care (Full Study)Phase 4<1 mi
Depemokimab Asthma Imaging and Bronchoscopy Sub-StudyPhase 3<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry—<1 mi
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications—<1 mi
Parkinson's Foundation PD GENEration Genetic Registry—<1 mi
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPhase 1<1 mi
Ribociclib And Endocrine Treatment of Physician's Choice for Locoregional Recurrent, Resected Hormone Receptor Positive HER2 Negative Breast CancerPhase 2<1 mi
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast CancerPhase 3<1 mi
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrencePhase 3<1 mi
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerPhase 3<1 mi
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast CancerPhase 3<1 mi
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast CancerPhase 2<1 mi
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)Phase 3<1 mi
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid TumorsPhase 1<1 mi
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast CancerPhase 1<1 mi
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationPhase 3<1 mi
Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell CarcinomaPhase 1<1 mi
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine TumorsPhase 1<1 mi
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H MutationPhase 1<1 mi
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CPPhase 2<1 mi
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 RearrangementsPhase 1/2<1 mi
A Phase 1/1b Study of IAM1363 in HER2 CancersPhase 1<1 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)Phase 3<1 mi
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With OsteosarcomaPhase 3<1 mi
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP DeletionPhase 1<1 mi
TTX-080 HLA-G Antagonist in Subjects With Advanced CancersPhase 1<1 mi
A Study of Methylprednisolone in People Having Liver SurgeryPhase 3<1 mi
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry—<1 mi
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular CarcinomaPhase 3<1 mi
Registry Study for Radiation Therapy Outcomes—<1 mi
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy—<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular DiseasePhase 3<1 mi
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPhase 3<1 mi
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney FunctionPhase 3<1 mi
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and ObesityPhase 3<1 mi
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous MelanomaN/A<1 mi
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyrosine Kinase Mutation (FLT3 Mut+)Phase 1<1 mi
Assessment of CCM in HF With Higher Ejection FractionN/A<1 mi
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial FibrillationPhase 3<1 mi
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects—<1 mi
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular InterventionPhase 4<1 mi
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.Phase 3<1 mi
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMRN/A<1 mi
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCCPhase 3<1 mi
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive SymptomsPhase 4<1 mi
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)Phase 2<1 mi
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive DisorderPhase 3<1 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)Phase 3<1 mi
Product Surveillance Registry—<1 mi
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACSPhase 3<1 mi
Single Chamber Atrial Leadless Pacing for Isolated Sinus Node Dysfunction—<1 mi
Does Batten Grafting Improve Nasal Outcomes in Septoplasty and Turbinate Reduction?N/A<1 mi
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)Phase 2<1 mi
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus TrastuzumabPhase 3<1 mi
Evaluating the Implementation of a Comprehensive Multilevel Virtual Oncology Program Among Veterans Diagnosed With Lung, Colorectal, Prostate, and Breast Cancers in the US Department of Veterans AffairsN/A<1 mi
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityPhase 3<1 mi
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisPhase 3<1 mi
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver FibrosisPhase 3<1 mi
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 3<1 mi
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 2<1 mi
Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell CarcinomaPhase 3<1 mi
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)Phase 3<1 mi
Validating CGM for GDMN/A<1 mi
Chatbot to Maximize Hereditary Cancer Genetic Risk AssessmentN/A<1 mi
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple MyelomaPhase 3<1 mi
A Study of Pasritamig (JNJ-78278343) in Combination With Other Agents for Metastatic Prostate CancerPhase 1<1 mi
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate CancerPhase 1<1 mi
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma SubjectsPhase 1<1 mi
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation—<1 mi
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate CancerPhase 1/2<1 mi
Using Middle School Science Teachers to Address Cancer Health DisparitiesN/A<1 mi
A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)Phase 3<1 mi
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric AdenocarcinomaPhase 3<1 mi
Trial of Combined Obstetric Carrier Screening and Hereditary Cancer ScreeningN/A<1 mi
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal CancerPhase 3<1 mi
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix CancerN/A<1 mi
International Registry for Men With Advanced Prostate Cancer (IRONMAN)—<1 mi
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth—<1 mi
Rare and Atypical Diabetes Network—<1 mi
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive DisorderPhase 3<1 mi
Lay-Delivered Behavioral Activation in Senior CentersN/A<1 mi
Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPhase 3<1 mi
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive DisorderPhase 3<1 mi
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease DementiaPhase 2/3<1 mi
Study to Evaluate Safety, Tolerability and Drug Levels of BMS-986435/MYK-224 in Participants With Heart Failure With Preserved Ejection Fraction (HFpEF)Phase 2<1 mi
MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small VesselsN/A<1 mi
STICH3C Cardiac Magnetic Resonance Observational Study—<1 mi
Randomization of Single vs Multiple Arterial GraftsN/A<1 mi
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary LesionsN/A<1 mi
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors—<1 mi
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in WomenN/A<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With GoutPhase 3<1 mi
Clinical Trial on Agitation in Alzheimer's DementiaPhase 2<1 mi
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus ErythematosusPhase 3<1 mi
Personalized Second Chance Breast Conservation (PSCBC): A Prospective Phase II Clinical StudyN/A<1 mi
ATEMPT 2.0: Adjuvant T-DM1 vs THPhase 2<1 mi
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)Phase 3<1 mi
The PREDICT Registry:—<1 mi
Decision Support Tool for Patients With Advanced Breast CancerN/A<1 mi
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer PatientsN/A<1 mi
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)Phase 3<1 mi
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorPhase 3<1 mi
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung CancerPhase 3<1 mi
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung CancerPhase 3<1 mi
A Study of Sigvotatug Vedotin in Advanced Solid TumorsPhase 1<1 mi
A Study of BMS986365 in Combination With Degarelix in People With Prostate CancerPhase 2<1 mi
A Study of Bexarotene Combined With Radiotherapy in People With Mycosis FungoidesPhase 1<1 mi
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesPhase 3<1 mi
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 3<1 mi
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)Phase 3<1 mi
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)Phase 3<1 mi
Quality of Pediatric Resuscitation in a Multicenter Collaborative—<1 mi
Primary Subtalar Arthrodesis for Calcaneal FracturesN/A<1 mi
Phase IIIb Study of Ribociclib + ET in Early Breast CancerPhase 3<1 mi
An Acupuncture Study for Cancer Survivors With Joint PainN/A<1 mi
A Study of a Distress Screening and Referral Program in People With Recently Diagnosed CancerN/A<1 mi
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated SarcomasPhase 3<1 mi
Responses to Genetic Risk Modifier Testing Among Women With Pathogenic Variants in Breast Cancer Predisposition Genes—<1 mi
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments—<1 mi
The FLOTILLA Study: Providing Continued Access to The Study Medicines Encorafenib and Binimetinib for Participants in Prior Clinical TrialsPhase 4<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With AsthmaPhase 3<1 mi
Gadopiclenol in Contrast Enhanced MRI of the ProstatePhase 4<1 mi
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate CancerPhase 2<1 mi
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)Phase 1/2<1 mi
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With CancerPhase 2<1 mi
Study of AZD0754 in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
New MRI Biomarkers in Head and Neck Cancers—<1 mi
A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)Phase 1<1 mi
A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric CancerPhase 3<1 mi
Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid TumorsPhase 1<1 mi
68-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.Phase 4<1 mi
A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid TumoursPhase 1/2<1 mi
Remote Digital Physiologic Data Collection in Cancer: An MSK Registry Protocol—<1 mi
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid LeukemiasPhase 1<1 mi
A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade GliomaPhase 1<1 mi
Registry to Collect Health Information About Desmoplastic Small Round Cell Tumor—<1 mi
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck CancerPhase 3<1 mi
Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic LeukemiaPhase 2<1 mi
A First-in-Human Study of BMS-986506 in Participants With Advanced Clear Cell Renal Cell Carcinoma (ccRCC)Phase 1<1 mi
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal CancerPhase 1<1 mi
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 2<1 mi
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)Phase 1/2<1 mi
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AMLPhase 1<1 mi
Adoptive Cell Therapy Long-term Follow-up (LTFU) StudyPhase 1<1 mi
CD4CAR for CD4+ Leukemia and LymphomaPhase 1<1 mi
A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic LeukemiaPhase 3<1 mi
Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary DiversionN/A<1 mi
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromePhase 1<1 mi
A Study of Azenosertib (ZN-c3) in Patients With Ovarian CancerPhase 1<1 mi
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia GravisPhase 3<1 mi
Surgical Pembro +/- Olaparib w TMZ for rGBMPhase 2<1 mi
A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial CarcinomaPhase 1<1 mi
Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA TherapyPhase 3<1 mi
SPEARHEAD-3 Pediatric StudyPhase 1/2<1 mi
Phase II Investigation of Pembrolizumab in Combination With Bevacizumab and Oral Cyclophosphamide in Patients With High Grade Ovarian Cancer and Surgically Documented Minimal Residual Disease After Frontline TherapyPhase 2<1 mi
Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell LymphomaPhase 1/2<1 mi
Surgical Tissue Flap to Bypass the Blood Brain Barrier in GlioblastomaN/A<1 mi
A Study of ASP1002 in Adults for Treatment of Solid TumorsPhase 1<1 mi
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or ParagangliomaPhase 2<1 mi
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell LymphomaPhase 3<1 mi
Cabozantinib for Patients With Recurrent or Progressive MeningiomaPhase 2<1 mi
Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 Alone and in Combination in Patients With Selected Solid TumorsPhase 1/2<1 mi
Metastatic Leiomyosarcoma Biomarker Protocol—<1 mi
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaPhase 1<1 mi
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 SystemPhase 1/2<1 mi
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)Phase 1<1 mi
A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)Phase 1/2<1 mi
MAPK Inhibition Combined With Anti-PD1 Therapy for BRAF-altered Pediatric GliomasPhase 1/2<1 mi
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other TreatmentsPhase 3<1 mi
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related ValuesN/A<1 mi
A Phase 1/2 Study of D3S-002 as Monotherapy or Combination Therapy in Adult Subjects With Advanced Solid Tumors With MAPK Pathway MutationsPhase 1/2<1 mi
Precision Medicine Study—<1 mi
Universal Genetic Testing for Cancer Risk ReductionN/A<1 mi
A Study of Noninvasive Methods to Evaluate Skin and Mucosal Conditions—<1 mi
ZEN003694 and Enzalutamide Versus Enzalutamide Monotherapy in Metastatic Castration-Resistant Prostate CancerPhase 2<1 mi
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)Phase 1<1 mi
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9Phase 1/2<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)Phase 1/2<1 mi
Open-Label Study to Evaluate the Safety, Tolerability and Efficacy of the Oncolytic HSV1 MVR-C5252Phase 1<1 mi
Tumor Microenvironment Analysis of Prostate Cancer Metastasis—<1 mi
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib TherapyPhase 3<1 mi
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Screening Women With Prior HPV for Anal NeoplasiaN/A<1 mi
Combination Therapy for the Treatment of Diffuse Midline GliomasPhase 2<1 mi
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma—<1 mi
A Study of ARC-02 in B-cell NHLPhase 1<1 mi
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) PirtobrutinibPhase 4<1 mi
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated GliomaPhase 1/2<1 mi
Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaPhase 2<1 mi
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active SurveillancePhase 2<1 mi
A Study of BGB-16673 Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) InhibitorsPhase 3<1 mi
Tissue Collection for Drug Screening and Bioanalysis—<1 mi
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)Phase 1<1 mi
A Bilingual Virtually-based Intervention (PEDALL) for the Prevention of Weight Gain in Childhood ALL Patients Considering Key Genetic and Sociodemographic Risk FactorsN/A<1 mi
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy SpecimenN/A<1 mi
Avutometinib and Defactinib in Diffuse Gastric CancerPhase 2<1 mi
Investigating an mRNA CAR T-cell Therapy, Known as Descartes-08, as a Potential Approach to Treat Myasthenia GravisPhase 3<1 mi
Pilot Testing of a Colorectal Cancer Education ProgramN/A<1 mi
Psilocybin Therapy in Advanced CancerPhase 2/3<1 mi
Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic SyndromesPhase 1<1 mi
A Study of Codrituzumab in Children and Young Adults With Solid Tumors and Have Not Responded to Treatment or Have Come Back After TreatmentPhase 1<1 mi
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyPhase 3<1 mi
Upright MRI for Prostate Cancer Screening—<1 mi
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer—<1 mi
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic LeukemiaPhase 1/2<1 mi
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid LeukemiaPhase 1/2<1 mi
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell SarcomaPhase 2<1 mi
A Study of PHST001 in Advanced Solid TumorsPhase 1<1 mi
A First-in-Human Study of YL217 in Patients With Advanced Solid TumorsPhase 1<1 mi
Retrospective Review of Esophageal Cancer at MSKCC—<1 mi
Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NETPhase 3<1 mi
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair GenesPhase 1<1 mi
A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid TumorsPhase 1<1 mi
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple MyelomaPhase 2<1 mi
Alpha Radiation Emitters (DaRT) With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic CancerN/A<1 mi
Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)Phase 2<1 mi
Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)Phase 3<1 mi
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.Phase 1/2<1 mi
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)Phase 3<1 mi
Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin CancerPhase 1/2<1 mi
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1<1 mi
Blue Light Cystoscopy With Cysview® Registry—<1 mi
FUS Etoposide for DMGPhase 1<1 mi
Ablative Therapy in the Management of Prostate Cancer—<1 mi
Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors—<1 mi
Decision Aid (DA) for Renal PatientsN/A<1 mi
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)Phase 2<1 mi
Food and Microbiome Longitudinal Investigation (FAMiLI)—<1 mi
Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract CancerPhase 3<1 mi
Psychotherapy Intervention for Latinos With Advanced CancerN/A<1 mi
Phase 1b/2a Randomized Double-blind Study to Investigate Safety Tolerability PK PD Preliminary Efficacy of Oral Administration of SNIPR001 in Patients With Hematologic Malignancy Scheduled for Allogeneic Hematopoietic Stem-Cell Transplant Receiving FQ Prophylaxis & Harboring FQR Ecoli Pre-TransplantPhase 1/2<1 mi
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)—<1 mi
Precision-Based Genomics in Prostate Cancer—<1 mi
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)Phase 1<1 mi
Identification and Treatment Of Micrometastatic Disease in Stage III Colon CancerPhase 3<1 mi
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate CancerPhase 1<1 mi
Comprehensive Assessment of Cancer Theranostic ResponseN/A<1 mi
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)Phase 1/2<1 mi
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their BladderPhase 2<1 mi
A Study of Zanzalintinib in Participants With Recurrent or Progressive MeningiomaPhase 2<1 mi
Testing Gene PilotLX With Latinx Cancer PatientsN/A<1 mi
Combination Immunotherapy for the Treatment of Chemotherapy-refractory Metastatic MSS CRCPhase 1/2<1 mi
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX OverexpressionPhase 1/2<1 mi
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)Phase 1/2<1 mi
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)Phase 1<1 mi
A Study of Toripalimab in Combination With Cisplatin and Gemcitabine in Participants With Recurrent Metastatic Nasopharyngeal CancerPhase 4<1 mi
Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial CancerPhase 1/2<1 mi
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of PreventionN/A<1 mi
An Extension Study for Patients Previously Enrolled in Studies With PelabresibPhase 3<1 mi
Actinium Therapy for Late-stage Aggressive SarcomasPhase 1<1 mi
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1<1 mi
First in Human Study of TORL-1-23 in Participants With Advanced CancerPhase 1<1 mi
A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasPhase 1/2<1 mi
A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid TumorsPhase 1<1 mi
SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid HemangioendotheliomaPhase 2<1 mi
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and RevumenibPhase 1/2<1 mi
Decentralized Clinical Trial of Effectiveness of EnergyPoints App in Cancer SurvivorsN/A<1 mi
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic CarcinomaPhase 1/2<1 mi
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsN/A<1 mi
BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell LymphomaPhase 2<1 mi
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction—<1 mi
Super Selective Intra-arterial Repeated Infusion of Cetuximab (Erbitux) With Reirradiation for Treatment of Relapsed/Refractory GBM, AA, and AOAPhase 2<1 mi
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell CarcinomaPhase 1<1 mi
Asciminib Roll-over StudyPhase 4<1 mi
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI DiscontinuationPhase 2<1 mi
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid LeukemiaPhase 1<1 mi
Navigating Financial and Health-Related Social Needs in Adolescent and Young Adult Cancer Survivors (AYA-NAV)N/A<1 mi
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerPhase 3<1 mi
Collection and Storage of Tissue and Blood Samples From Patients With Cancer—<1 mi
CUIMC Focal Therapy Registry—<1 mi
Confocal Laser Endomicroscopy as an Imaging Biomarker for the Diagnosis of Pancreatic Cystic Lesions—<1 mi
Effects of Belzutifan on 89Zr-DFO-girentuximab PET Uptake in Patients With Renal Cell Carcinoma (RCC)Phase 1<1 mi
Study of Patritumab Deruxtecan in Participants With Gastrointestinal Cancers (MK-1022-011) (HERTHENA-PanTumor02)Phase 1/2<1 mi
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 SystemPhase 1/2<1 mi
Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid LeukemiaPhase 1<1 mi
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE TrialPhase 2/3<1 mi
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin OintmentPhase 1/2<1 mi
A Study of CTD402 in T-ALL/LBL PatientsPhase 1/2<1 mi
A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced MalignanciesPhase 1/2<1 mi
A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)Phase 1<1 mi
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other TumorsPhase 1/2<1 mi
Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial CancerPhase 2<1 mi
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or AstrocytomaPhase 1<1 mi
A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal MelanomaPhase 3<1 mi
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and ProvidersN/A<1 mi
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder CancerPhase 2<1 mi
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome—<1 mi
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic AlterationsPhase 2<1 mi
A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian CancerPhase 2<1 mi
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsPhase 2<1 mi
Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral NeuropathyPhase 3<1 mi
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell TransplantationPhase 2<1 mi
Pacritinib in CMMLPhase 1/2<1 mi
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After ImmunotherapyPhase 2/3<1 mi
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT StudyPhase 2<1 mi
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)Phase 3<1 mi
Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube CancerPhase 3<1 mi
Adaptive Treatment De-escalation in Favorable Risk HPV-Positive Oropharyngeal CarcinomaPhase 2<1 mi
A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid LeukemiaPhase 1<1 mi
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 MutationPhase 1/2<1 mi
Study of BMS-986497 (ORM-6151) as a Monotherapy, in Double and Triple Combination With Azacitidine and Venetoclax in Participants With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromePhase 1<1 mi
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.Phase 2<1 mi
A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian CancerPhase 1/2<1 mi
A Study of YL201 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)Phase 3<1 mi
Epco, Zanu, Ritux for R/R FL or MZLPhase 2<1 mi
Study of IBI3020 Treatment in Participants With Late-Stage Solid TumorsPhase 1<1 mi
Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCCPhase 2<1 mi
A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D MutationPhase 1<1 mi
Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma (NLPHL)—<1 mi
A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815Phase 1<1 mi
Radiofrequency Ablation Study in LatinX PatientsN/A<1 mi
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple MyelomaPhase 1/2<1 mi
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesPhase 1<1 mi
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Newly Diagnosed, Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorPhase 1/2<1 mi
Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 3<1 mi
Trial of Spiritual Care Interventions for Patients With CancerN/A<1 mi
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell CancerPhase 2<1 mi
Childhood Cancer Survivor Study—<1 mi
Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 MutationPhase 1<1 mi
A Clinical Study of Intismeran Autogene (V940) and BCG in People With Bladder Cancer (V940-011/INTerpath-011)Phase 2<1 mi
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid MalignanciesPhase 1<1 mi
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)Phase 3<1 mi
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)Phase 1<1 mi
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic PhasePhase 2<1 mi
Repeated Superselective Intraarterial Cerebral Infusion (SIACI) of Bevacizumab With Temozolomide and Radiation Compared to Temozolomide and Radiation Alone in Newly Diagnosed GBMPhase 3<1 mi
A Study to Evaluate the Safety, Tolerability of INCB160058 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
NYC Cancer Outreach Network in Neighborhoods for Equity and Community TranslationN/A<1 mi
A Study of XB628 Alone and in Combination With Zanzalintinib in Participants With Recurrent Advanced or Metastatic Solid TumorsPhase 1<1 mi
Diphencyprone Plus Immune Checkpoint Inhibition in the Treatment of Cutaneous MetastasesPhase 1<1 mi
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological MalignanciesPhase 1<1 mi
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian CancerPhase 3<1 mi
TLN-372 in Advanced KRAS Mutant Solid TumorsPhase 1<1 mi
Olutasidenib DDI Study in Patients With IDH1 Mutation Positive MalignanciesPhase 4<1 mi
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate CancerPhase 3<1 mi
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)Phase 2<1 mi
Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal CancerPhase 1/2<1 mi
A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical TrialsPhase 3<1 mi
First-in-Human Study of ADCE-D01 in Soft Tissue SarcomaPhase 1/2<1 mi
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot StudyPhase 2<1 mi
Study of the Efficacy of Intratumoral L19IL2 or L19TNF or L19IL2/L19TNF, in Combination with Pembrolizumab, in Unresectable Melanoma PatientsPhase 2<1 mi
A Study of ASP3082 in Adults With Advanced Solid TumorsPhase 1<1 mi
Concurrent XRD-0394 With Radiation Therapy for High Grade GliomasEarly 1<1 mi
A Study of a Vaccine in Combination With β-glucan and GM-CSF in People With NeuroblastomaPhase 2<1 mi
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal CancerPhase 1/2<1 mi
Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of BL-M05D1 in Subjects With Solid TumorsPhase 1<1 mi
Cryopreservation of Ovarian TissueN/A<1 mi
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed GlioblastomaPhase 1/2<1 mi
In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PETEarly 1<1 mi
A Study to Evaluate Safety, PK, PD and Efficacy of AZD5492, a T Cell-engaging Antibody Targeting CD20 in Subjects With R/R B-Cell Malignancies.Phase 1/2<1 mi
EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed GlioblastomaPhase 3<1 mi
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell MalignanciesPhase 1/2<1 mi
TINI 2: Total Therapy for Infants With Acute Lymphoblastic Leukemia IIPhase 1/2<1 mi
A Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)Phase 1/2<1 mi
ORIC-114 in Combination With Subcutaneous Amivantamab in Patients With EGFR Exon20 Insertion Mutant NSCLCPhase 1<1 mi
Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic CancerPhase 2/3<1 mi
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted ChemotherapyPhase 2<1 mi
Feasibility Trial of Combination of Obstetrical Carrier Screening and Hereditary Cancer ScreeningN/A<1 mi
Retinoblastoma Phase II Expanded Access Clinical TrialPhase 2<1 mi
Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic AdenocarcinomaPhase 2<1 mi
Safety and Preliminary Efficacy of OBT076 in Recurrent/Metastatic CD205+ Solid TumorsPhase 1<1 mi
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound—<1 mi
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With CancerPhase 3<1 mi
Prospective Study to Assess a Diagnostic Aid for Cancer—<1 mi
Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma—<1 mi
DALY II USA/ MB-CART2019.1 for DLBCLPhase 2<1 mi
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.Phase 2<1 mi
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate CancerPhase 1<1 mi
A Study of Emapalumab for Pediatric Aplastic AnemiaPhase 2<1 mi
Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort StudyN/A<1 mi
Registry to Collect Data on Patients Undergoing Segmental Mandibular Defect Reconstruction Following Oral Squamous Cell Carcinoma Resection and Drugs-induced Osteonecrosis—<1 mi
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic LeukemiaPhase 1<1 mi
Pembrolizumab, Ibrutinib and Rituximab in PCNSLPhase 1/2<1 mi
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy—<1 mi
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain CancerPhase 1<1 mi
Study of TVB-2640 in Men With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to TherapyPhase 1<1 mi
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaPhase 3<1 mi
A Phase 1 Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid TumorsPhase 1<1 mi
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate CancerPhase 2/3<1 mi
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing SurveillanceN/A<1 mi
Amping up With PemJAKPhase 2<1 mi
Study of REM-422 in Patients With AML or Higher Risk MDSPhase 1<1 mi
A Study of ZL-1310 in Participants With Selected Solid TumorsPhase 1/2<1 mi
Observing People With Desmoid-Type Fibromatosis—<1 mi
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant DisordersPhase 2<1 mi
Isatuximab During Stem Cell Collection and Transplant in Patients With Multiple Myeloma and LymphomaPhase 2<1 mi
Neurofibromatosis (NF) Registry Portal—<1 mi
RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study—<1 mi
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and AnemiaPhase 1/2<1 mi
A Study of D3L-001 as Monotherapy in Subjects With HER2-Positive Advanced Solid TumorsPhase 1<1 mi
Determining Whether Multiple Anesthesia Exposures Affect Cognitive Function for Retinoblastoma Patients—<1 mi
MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)—<1 mi
Study of a Communication Training Intervention for Large B-Cell Lymphoma ProvidersN/A<1 mi
Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian CancerPhase 1<1 mi
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaPhase 1<1 mi
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and LymphomaPhase 1/2<1 mi
Colonoscopy vs Stool Testing for Older Adults With Colon PolypsN/A<1 mi
Environmental Factors and Thyroid Cancer—<1 mi
Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia VeraPhase 3<1 mi
A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)Phase 1<1 mi
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active SurveillancePhase 2<1 mi
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid CarcinomaPhase 1<1 mi
Personalized Models for Cancer Research—<1 mi
Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and EpendymomaN/A<1 mi
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)N/A<1 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AMLPhase 1/2<1 mi
Evaluation of Grief Therapy Approaches for Bereaved ParentsN/A<1 mi
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)Phase 2<1 mi
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, Dedifferentiated Liposarcoma, or AngiosarcomaPhase 1<1 mi
A Study of Valemetostat Tosylate in Combination With DXd ADCs in Subjects With Solid TumorsPhase 1<1 mi
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaPhase 3<1 mi
Intent of Surgery for IPMN—<1 mi
A New Psychotherapy Intervention for Older Cancer PatientsN/A<1 mi
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder CancerPhase 2<1 mi
Taxi ROADmAP (Realizing Optimization Around Diet And Physical Activity)Phase 2<1 mi
Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment RegimenPhase 3<1 mi
Auditory Brainstem Implant (ABI) in Children With No Cochleae or Auditory NervesN/A<1 mi
A Phase 1/2 Study of STP938 (Dencatistat) for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell LymphomasPhase 1/2<1 mi
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial CancerPhase 1/2<1 mi
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate CancerPhase 2<1 mi
CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)Phase 1<1 mi
Study of How People Make Decisions About Prostate Cancer Risk—<1 mi
Interrogation of Exosome-mediated Intercellular Signaling in Patients With Pancreatic Cancer—<1 mi
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic LeukemiaPhase 1/2<1 mi
Sacral Neuromodulation for Male Overactive Bladder (MOAB)N/A<1 mi
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic SyndromePhase 1<1 mi
Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin LymphomaPhase 1<1 mi
Two Fraction Prostate SBRT With DIL SIBPhase 1<1 mi
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)Phase 1/2<1 mi
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal CancerPhase 3<1 mi
A First-in-Human Trial of DS3790a in Participants With Hematological MalignanciesPhase 1/2<1 mi
Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including SarcomasPhase 1<1 mi
A Study to Learn About the Study Medicine Bosulif in Adult Patients With Chronic Myeloid Leukemia(CML).—<1 mi
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion Alone or in Combination With Oral, IV, Subcutaneous Daratumumab; Lenalidomide; Dexamethasone; CarfilzomibPhase 1/2<1 mi
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)Phase 3<1 mi
Outcomes of Low-Risk Endometrial Cancer With Isolated Tumor Cells in the Sentinel Lymph Nodes: A Prospective, Multicenter, Single-Arm Observational Study—<1 mi
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With CancerPhase 2<1 mi
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.Phase 3<1 mi
A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically RemovedPhase 1/2<1 mi
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid TumoursPhase 1/2<1 mi
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic CancersN/A<1 mi
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) CancersPhase 1/2<1 mi
A Safety Study of SEA-CD70 in Patients With Myeloid MalignanciesPhase 1<1 mi
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1<1 mi
A Study to Evaluate INCA035784 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations—<1 mi
An Investigational Study of BGB-58067 As a Single Agent and in Combination With Anticancer Agents in Participants With Advanced Solid TumorsPhase 1<1 mi
RCT of Olanzapine for Control of CIV in Children Receiving Highly Emetogenic ChemotherapyPhase 2<1 mi
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System—<1 mi
A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Phase 2<1 mi
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal MelanomaPhase 2/3<1 mi
Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent GlioblastomaN/A<1 mi
A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin LymphomasPhase 1/2<1 mi
Substudy 06D: Combination Therapies in Second Line (2L) Gastroesophageal Adenocarcinoma (MK-3475-06D/Keymaker-U06)Phase 1/2<1 mi
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided RadiotherapyN/A<1 mi
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
Sequential Therapy in Multiple Myeloma Guided by MRD AssessmentsPhase 2<1 mi
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)Phase 1/2<1 mi
A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered MalignanciesPhase 1/2<1 mi
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab AdizutecanPhase 2<1 mi
Subcutaneous Talquetamab in Elderly Patients With Multiple Myeloma in Early RelapsePhase 2<1 mi
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode SystemN/A<1 mi
R-MVST Cells for Treatment of Viral InfectionsPhase 1<1 mi
Study of Ifinatamab Deruxtecan (DS-7300a, I-DXd) in Participants With Advanced Solid Malignant TumorsPhase 1/2<1 mi
Testing the Addition of an Anti-cancer Drug, DT2216, to the Usual Chemotherapy Treatment for Relapsed or Refractory Solid Tumors and Fibrolamellar CarcinomaPhase 1/2<1 mi
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)Phase 2<1 mi
Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic AdenocarcinomaPhase 3<1 mi
Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE TrialPhase 3<1 mi
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade DysplasiaN/A<1 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)Phase 2/3<1 mi
A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)Phase 1/2<1 mi
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial CancerPhase 2<1 mi
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine TumorsPhase 2/3<1 mi
Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell LymphomaPhase 2<1 mi
A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for TransplantPhase 2/3<1 mi
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials—<1 mi
Pan Tumor Rollover StudyPhase 2<1 mi
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)Phase 3<1 mi
Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsPhase 2<1 mi
Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)Phase 2<1 mi
Anti-tumour Activity of (177Lu) rhPSMA-10.1 InjectionPhase 1/2<1 mi
Study of HLD-0915 in Patients With Metastatic Prostate CancerPhase 1/2<1 mi
Characterization of Hyperpolarized Pyruvate MRI ReproducibilityN/A<1 mi
Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine GliomaPhase 1<1 mi
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to TreatmentPhase 2<1 mi
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral EventsPhase 2<1 mi
A Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With Relapsed or Refractory and Lenalidomide-exposed Multiple Myeloma (QUINTESSENTIAL-2)Phase 3<1 mi
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)Phase 3<1 mi
Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1Phase 2<1 mi
Specimen Collection for Validation of UroAmp: A Next Generation Sequencing Platform for Detection and Surveillance of Bladder Cancer—<1 mi
Photopheresis in Early-stage Mycosis FungoidesPhase 2<1 mi
Tislelizumab in People With Colorectal CancerPhase 2<1 mi
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS)Phase 3<1 mi
A Study of a Urine Test to Detect Colorectal Cancer—<1 mi
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaPhase 2<1 mi
A Study to Evaluate Efficacy and Safety of Ciltacabtagene AutoleucelPhase 2<1 mi
Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced MalignanciesPhase 1/2<1 mi
Study Evaluating Dosimetry, Randomized Dose Optimization, Dose Escalation and Efficacy of Ac-225 Rosopatamab Tetraxetan in Participants With PSMA PET-Positive Castration-Resistant Prostate Cancer (CRPC)Phase 2<1 mi
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Alectinib in Pediatric Participants With ALK Fusion-Positive Solid or CNS TumorsPhase 1/2<1 mi
International Rare Histiocytic Disorders Registry (IRHDR)—<1 mi
Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront ChemoimmunotherapyPhase 2<1 mi
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01D/LIGHTBEAM-U01)Phase 1/2<1 mi
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)Phase 1/2<1 mi
INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)Phase 2<1 mi
A Study of 177Lu-FAP-2286 in Advanced Solid TumorsPhase 1/2<1 mi
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer SurgeryN/A<1 mi
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care TreatmentsPhase 1<1 mi
Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or AstrocytomaPhase 1<1 mi
CATALINA-4: A Study to Investigate the Safety and Efficacy of TORL-1-23 With Chemotherapy Given Before Initial Surgery in Women With Advanced Stage Ovarian CancerPhase 1/2<1 mi
Low-Dose Radiotherapy in Treating Painful Bone Metastases in Patients With Multiple MyelomaN/A<1 mi
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Adult Participants With Previously Untreated Follicular LymphomaPhase 3<1 mi
QTX3034 in Patients With KRAS G12D MutationPhase 1<1 mi
A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Mature B-Cell Non-Hodgkin LymphomaPhase 1/2<1 mi
A Study to Evaluate Investigational Agents With or Without Pembrolizumab (MK-3475) in Participants With Advanced Esophageal Cancer Previously Exposed to Programmed Cell Death 1 Protein (PD-1)/ Programmed Cell Death Ligand 1 (PD-L1) Treatment (MK-3475-06B)Phase 1/2<1 mi
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AAPhase 1/2<1 mi
A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX GenesPhase 2<1 mi
A Study to Investigate Progression-Free Survival With Sonrotoclax Plus Obinutuzumab Or Sonrotoclax Plus Rituximab Compared With Venetoclax Plus Rituximab Treatment In Patients With Relapsed and/or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CELESTIAL-RRCLL)Phase 3<1 mi
RFA for Superficial LipomasN/A<1 mi
Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell TumoursPhase 3<1 mi
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaPhase 1/2<1 mi
Study of CAR-T Therapy in Older Patients—<1 mi
The SUGAR Study; SBRT and Relugolix) for Prostate CancerPhase 2<1 mi
A Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment—<1 mi
Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)Phase 2<1 mi
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal AdenocarcinomaPhase 2<1 mi
A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.Phase 1/2<1 mi
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple MyelomaPhase 1/2<1 mi
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal AdenocarcinomaPhase 3<1 mi
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone AcetatePhase 2<1 mi
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)Phase 3<1 mi
A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study to Investigate Safety and Effectiveness of BGB-16673 in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell MalignanciesPhase 1/2<1 mi
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid TumorsPhase 1<1 mi
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)Phase 1<1 mi
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell CarcinomaPhase 3<1 mi
A Study to Evaluate the Risk of Tumor Lysis Syndrome (TLS) in Adult Participants Receiving Oral Venetoclax in Combination With Intravenously Infused Obinutuzumab or Oral Acalabrutinib for Previously Untreated Chronic Lymphocytic Leukemia (CLL)Phase 3<1 mi
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) StudyPhase 3<1 mi
Psychotherapy Intervention for Latinos With Adv CancerN/A<1 mi
A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1Phase 2/3<1 mi
A Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismPhase 3<1 mi
A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NSPhase 1/2<1 mi
Cord Blood Transplant in Adults With Blood CancersPhase 2<1 mi
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete RemissionPhase 2<1 mi
Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)Phase 2<1 mi
A Study of the Use of Fat Flap Reconstruction to Reduce Neck Injury After Cancer TreatmentN/A<1 mi
Modified VR-CAP and Acalabrutinib as First Line Therapy for the Treatment of Transplant-Eligible Patients With Mantle Cell LymphomaPhase 2<1 mi
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage CancerPhase 2<1 mi
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCCPhase 2/3<1 mi
Evaluating the Long-term Safety and Tolerability of Imatinib in Patients With Lymphangioleiomyomatosis (LAM)Phase 1<1 mi
The Sinai Robotic Surgery Trial in HPV-related Oropharyngeal Squamous Cell Carcinoma (SIRS 2.0 Trial)Phase 2<1 mi
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce RecurrencePhase 2<1 mi
IVIG for Infection Prevention After CAR-T-Cell TherapyPhase 2<1 mi
A Study of TLN-254 in Participants With Relapsed or Refractory T-cell LymphomaPhase 1<1 mi
A Study of PYX-201 in Advanced Solid TumorsPhase 1<1 mi
Zanubrutinib, Obinutuzumab, and Sonrotoclax in Previously Untreated Patients With CLL or SLLPhase 2<1 mi
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell CarcinomaPhase 3<1 mi
Pancreas Registry and High Risk Registry—<1 mi
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate CancerPhase 2<1 mi
A Phase I, Open-label, Multicenter Study to Evaluate the Safety, Tolerability, Cellular Kinetics, Immunogenicity, Pharmacodynamics, and Preliminary Efficacy of AZD0120 in Participants With Multiple Myeloma (DURGA-2)Phase 1<1 mi
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)Phase 1/2<1 mi
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell LymphomaPhase 1/2<1 mi
Pleuroscopy First Versus Thoracentesis First in Patients With Suspected Malignant Pleural EffusionsN/A<1 mi
Avapritinib With Decitabine in Patients With SM-AHNPhase 1<1 mi
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)Phase 1/2<1 mi
A Study to Assess the Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-319 Moves Through the Bodies of Adult Participants With Relapsed or Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), or Chronic Lymphocytic Leukemia (CLL)Phase 1<1 mi
Substudy 03C: A Study of Combination Therapies in Participants With Renal Cell Carcinoma With Recurrent Disease During or After Anti-PD-(L)1 Therapy (MK-3475-03C/KEYMAKER-U03)Phase 1/2<1 mi
Study of SGR-3515 In Participants With Advanced Solid Tumors.Phase 1<1 mi
A Study of LY4584180 in Adult Participants With Previously Treated Blood CancersPhase 1<1 mi
Leading in MPNs Beyond Ruxolitinib in Combo With T-RegsPhase 1<1 mi
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)Phase 3<1 mi
Safety and Efficacy of SMART101 in Pediatric and Adult Patients With Hematological Malignancies After T Cell Depleted Allo-HSCTPhase 1/2<1 mi
Association Between Exercise, Patient-Reported Outcomes, and Clinical Events in Adult Cancer Survivors—<1 mi
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)—<1 mi
A Study of NEOK002, an EGFR and MUC1 Targeting Bispecific ADC, in Participants With Select Solid TumorsPhase 1<1 mi
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell TransplantationPhase 3<1 mi
Investigations of Reproductive Cancers in Women—<1 mi
Epcoritamab and Rituximab for First-line Follicular LymphomaPhase 2<1 mi
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic MalignanciesPhase 1<1 mi
Phase 1a/b Study of ZL-6201 Safety, PK, and Preliminary Efficacy in Sarcoma and Selected TumorsPhase 1<1 mi
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC FusionsPhase 1/2<1 mi
A Trial to Evaluate Intravesical Nadofaragene Firadenovec Alone or in Combination With Chemotherapy or Immunotherapy in Participants With High-grade BCG Unresponsive Non-muscle Invasive Bladder CancerPhase 3<1 mi
A First-in-human Study of RLY-8161 in Advanced NRAS-Mutant Solid TumorsPhase 1<1 mi
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)Phase 1/2<1 mi
Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATEPhase 4<1 mi
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort—<1 mi
Trial of Ixazomib for Kaposi SarcomaPhase 2<1 mi
Primary Tumor Research and Outcomes Network—<1 mi
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid LeukemiaPhase 1<1 mi
PediRISE FeasibilityN/A<1 mi
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)Phase 3<1 mi
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell MalignanciesPhase 1<1 mi
Tovorafenib for Treatment of Craniopharyngioma in Children and Young AdultsPhase 2<1 mi
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBCPhase 2<1 mi
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor CancerPhase 1/2<1 mi
CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)Phase 1<1 mi
A Study of MGC028 in Participants With Advanced Solid TumorsPhase 1<1 mi
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid TumorsPhase 1/2<1 mi
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBMPhase 1<1 mi
A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid TumorsPhase 1<1 mi
Selinexor and Backbone Treatments of Multiple Myeloma PatientsPhase 1/2<1 mi
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Study of Safety and Efficacy of RGT-61159 in Adults With Relapsed/Refractory Adenoid Cystic Carcinoma (ACC) or Colorectal Carcinoma (CRC)Phase 1<1 mi
Venetoclax and Obinutuzumab Followed by Epcoritamab for the Treatment of Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma, LonGEVity TrialPhase 2<1 mi
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)Phase 2<1 mi
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer PainN/A<1 mi
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple MyelomaPhase 1<1 mi
Longitudinal Oral Microbiome Sampling for BE—<1 mi
A Study of [18F]LY4214835 in Healthy Volunteers and Participants With CancerPhase 1<1 mi
A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)Phase 3<1 mi
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)—<1 mi
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLPhase 2<1 mi
Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed GlioblastomaPhase 2<1 mi
Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular LymphomaPhase 3<1 mi
A Study of SYNC-T Therapy SV-102 in Participants With Metastatic Castration-Resistant Prostate CancerPhase 2<1 mi
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid TumorsPhase 1<1 mi
Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell LymphomaPhase 3<1 mi
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)Phase 3<1 mi
Cord Blood Transplantation in Children and Young Adults With Blood CancerPhase 2<1 mi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial CancerPhase 3<1 mi
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPERPhase 2<1 mi
Omental Tissue Autograft in Human Recurrent Glioblastoma Multiforme (rGBM)N/A<1 mi
The Efficacy of Conventional Screening Versus mHealth Screening in Early Detection of Oral Potentially Malignant Disorders and Oral Cancer Amongst the Rural Population of Varanasi: A Prospective and Blinded Study—<1 mi
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T TherapyPhase 2<1 mi
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) AmyloidosisPhase 1<1 mi
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic LeukemiaPhase 2<1 mi
A Clinical Trial to Evaluate EDV Nanocell Therapy With Gemcitabine and Nab-paclitaxel in Pancreatic CancerPhase 1/2<1 mi
A Study of JNJ-95437446 in Participants With Advanced-Stage Solid TumorsPhase 1<1 mi
Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid TumorsN/A<1 mi
Trial Evaluating the Safety and Efficacy Of MR-Linac-Guided Radiotherapy as Salvage Treatment After External Beam Radiotherapy Recurrence (TUMORNATOR II)N/A<1 mi
Teclistamab-Daratumumab in AL AmyloidosisPhase 2<1 mi
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative NeoplasmsPhase 1<1 mi
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaPhase 2<1 mi
Pancreatic Cancer Early Detection Consortium—<1 mi
(Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisPhase 2<1 mi
Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaPhase 1<1 mi
Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High-grade Ovarian, Primary Peritoneal, or Fallopian Tube CancerPhase 2/3<1 mi
A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.Phase 2<1 mi
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate CancerPhase 1<1 mi
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic CancerPhase 2<1 mi
Study of INCA036978 in Participants With Myeloproliferative NeoplasmsPhase 1<1 mi
PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease—<1 mi
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancErN/A<1 mi
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative NeoplasmPhase 1<1 mi
A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin LymphomaPhase 4<1 mi
A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue SarcomaPhase 2<1 mi
Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)Phase 1<1 mi
Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBMPhase 1/2<1 mi
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)Phase 3<1 mi
Mechanisms of Resistance to PSMA Radioligand Therapy—<1 mi
Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory LymphomaPhase 1<1 mi
Anastomotic Safety and Surveillance Using Real-time Enhanced Sensing Using xBarN/A<1 mi
A Study of mRNA-2808 in Participants With Relapsed or Refractory Multiple MyelomaPhase 1/2<1 mi
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)Phase 1/2<1 mi
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal TumorsPhase 3<1 mi
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)Phase 3<1 mi
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple MyelomaPhase 1<1 mi
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)Phase 3<1 mi
SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous MelanomaPhase 3<1 mi
A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or UbamatamabPhase 1/2<1 mi
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)Phase 1<1 mi
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid TumorsPhase 1/2<1 mi
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell LymphomaPhase 2<1 mi
A Study to Investigate ANS03 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
R-MVST Cells for Treatment of Viral Infections in Children and Young AdultsPhase 1<1 mi
Study of SGR-1505 in Mature B-Cell NeoplasmsPhase 1<1 mi
A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic SyndromesPhase 1<1 mi
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment—<1 mi
Comprehensive Omics Analysis of Pediatric and Adult Solid Tumors and Establishment of a Repository for Related Biological Studies—<1 mi
ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCLN/A<1 mi
Simple Bone Cysts in KidsPhase 3<1 mi
The Ambient Light Multiple Myeloma StudyN/A<1 mi
Excision of Lymph Node Trial (EXCILYNT) (Mel69)N/A<1 mi
A Study of TAK-505 in Adults With Solid TumorsPhase 1/2<1 mi
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers—<1 mi
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)Phase 1<1 mi
A Study of CS5001 in Patients With Advanced Solid Tumors and LymphomasPhase 1<1 mi
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.Phase 3<1 mi
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)Phase 3<1 mi
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)Phase 2<1 mi
Chronic CED of TPT for Recurrent Malignant GliomaPhase 1<1 mi
Study of ORIC-944 in Patients With Metastatic Prostate CancerPhase 1<1 mi
Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic AdenocarcinomaPhase 2<1 mi
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerPhase 2/3<1 mi
A Phase I Study of SIM0505 in Participants With Advanced Solid TumorsPhase 1<1 mi
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban PopulationsN/A<1 mi
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial CarcinomaPhase 2/3<1 mi
A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsPhase 1<1 mi
Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced CancerN/A<1 mi
FITting Non-invasive Tests in Lynch Syndrome Surveillance—<1 mi
ctDNA-guided Addition of Ipilimumab to Patients Receiving Nivolumab and RelatlimabPhase 4<1 mi
A Study to Collect Information About the Use of Redifferentiating Medications as a Standard Treatment for Thyroid Cancer—<1 mi
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed GlioblastomaPhase 1/2<1 mi
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid TumorsPhase 1<1 mi
Evaluation of Stool Based Markers for the Early Detection of Colorectal Cancers and Adenomas—<1 mi
Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaPhase 1/2<1 mi
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has SpreadPhase 2<1 mi
Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder CancerPhase 3<1 mi
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher RiskN/A<1 mi
Correlation Vitamin D Level to Endocrine Autoimmune Toxicity Due to Immune Checkpoint Inhibitors—<1 mi
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)Phase 1<1 mi
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsPhase 1/2<1 mi
European Prospective Investigation Into Childhood Cancer—<1 mi
rTMS for Postoperative Brain Tumor PatientsN/A<1 mi
FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3Phase 1<1 mi
A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin LymphomaPhase 1/2<1 mi
ACTengine® IMA203 Combined With mRNA-4203Phase 1<1 mi
A Study of RNK05047 in Subjects With Advanced Solid Tumors/Diffuse Large B-cell Lymphoma (CHAMP-1)Phase 1/2<1 mi
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple MyelomaPhase 2<1 mi
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaEarly 1<1 mi
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell LymphomaPhase 1<1 mi
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPCPhase 3<1 mi
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serous Ovarian CancerPhase 3<1 mi
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate CancerPhase 1<1 mi
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate CancerPhase 3<1 mi
A Study of DaratumumabPhase 3<1 mi
Imetelstat Combinations in Relapsed AMLPhase 1<1 mi
Anti-GD2 ADC M3554 in Advanced Solid TumorsPhase 1<1 mi
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable TreatmentPhase 3<1 mi
Brentuximab Vedotin in Early Stage Hodgkin LymphomaPhase 3<1 mi
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid TumorsPhase 2<1 mi
Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV MelanomaPhase 2<1 mi
Carboplatin or Olaparib for BRcA Deficient Prostate CancerPhase 2<1 mi
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior ImmunotherapyPhase 1<1 mi
A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaPhase 4<1 mi
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate CancerPhase 1<1 mi
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate CancerPhase 1<1 mi
Safety, Pharmacokinetics, and Efficacy of AI-081, a Bispecific Antibody for PD-1 And VEGF in Advanced Solid TumorsPhase 1/2<1 mi
Clinical Trial of Approaches to Prostate Cancer SurgeryN/A<1 mi
A Multi Center Study of Sexual Toxicities After Radiotherapy—<1 mi
N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With NeuroblastomaPhase 2<1 mi
A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid TumorsPhase 1/2<1 mi
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract CancerPhase 3<1 mi
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer SurvivorsPhase 3<1 mi
IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic CancersPhase 1/2<1 mi
Neoadjuvant Darovasertib in Primary Uveal MelanomaPhase 3<1 mi
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid TumorsPhase 1<1 mi
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent GlioblastomaPhase 2/3<1 mi
Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid TumorsPhase 1<1 mi
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPALPhase 1<1 mi
Mobile Health Application (PACT) to Improve Engagement in Advance Care PlanningN/A<1 mi
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon CancerPhase 3<1 mi
An Acupuncture Study for People At High Risk for SepsisPhase 2<1 mi
A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid TumorsPhase 1<1 mi
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related DiseasesPhase 1<1 mi
BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)Phase 1/2<1 mi
Safety and Tolerability Study of GIM-531 in Advanced Solid TumorsPhase 1/2<1 mi
First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsPhase 1<1 mi
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid TumorsPhase 1<1 mi
(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic MastocytosisPhase 2/3<1 mi
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and LenalidomidePhase 3<1 mi
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic LeukaemiaPhase 1/2<1 mi
Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate CancerPhase 2<1 mi
Registry for Esophageal and Gastroesophageal Junction Cancer—<1 mi
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)Phase 3<1 mi
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid TumorsPhase 1/2<1 mi
Study to Evaluate VT3989 in Patients With Metastatic Solid TumorsPhase 1/2<1 mi
Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.Phase 3<1 mi
MethoTRExATE in MyelOpRolifErative Neoplasms (TREATMORE) TrialPhase 2<1 mi
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell CarcinomaPhase 1<1 mi
Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)Phase 2<1 mi
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCsN/A<1 mi
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.Phase 1<1 mi
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 OverexpressionPhase 2<1 mi
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerPhase 3<1 mi
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate TreatmentPhase 3<1 mi
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable CancersPhase 1<1 mi
Stereotactic MRI-guided Focused Ultrasound MesencephalotomyN/A<1 mi
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)Phase 1/2<1 mi
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia—<1 mi
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness—<1 mi
A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) TumorsPhase 1/2<1 mi
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's TransformationPhase 2<1 mi
Neurocutaneous Melanocytosis Registry—<1 mi
Adaptive Radiation in Anal CancerN/A<1 mi
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)Phase 3<1 mi
Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer PatientsN/A<1 mi
TLN-121 in Relapsed or Refractory Non-Hodgkin LymphomasPhase 1<1 mi
A Study to Learn About the Study Medicine PF-08052667 in People With Bladder CancerPhase 1<1 mi
Lurbinectedin in FET-Fused TumorsPhase 1/2<1 mi
MB-105 in Patients With CD5 Positive T-cell LymphomaPhase 2<1 mi
Limited-duration TeclistamabPhase 2<1 mi
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer—<1 mi
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT TrialPhase 2<1 mi
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid TumorsPhase 2<1 mi
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)Phase 2/3<1 mi
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction CancerPhase 3<1 mi
A Study in People With Advanced Cancer to Test How Well Different Doses of BI 3819026 Are Tolerated When Taken Alone and Together With EzabenlimabPhase 1<1 mi
Screening for AL Amyloidosis in Smoldering Multiple Myeloma—<1 mi
Rapid Sequencing of Approved Therapies in Patients with Metastatic or Unresectable Clear Cell Renal Cell CarcinomaEarly 1<1 mi
Tissue Repository: CTCL Collection Protocol—<1 mi
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple MyelomaPhase 2<1 mi
A Study of Time-Restricted Eating in Childhood Cancer SurvivorsN/A<1 mi
A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.Phase 1/2<1 mi
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Phase 2<1 mi
Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBMPhase 3<1 mi
Trastuzumab Deruxtecan (T-DXd) for People With Brain CancerPhase 2<1 mi
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate CancerPhase 1/2<1 mi
AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant Prostate Cancer (CRPC)Phase 1/2<1 mi
A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyPhase 2<1 mi
Cholesterol Lowering and Residual Risk in Diabetes, Type 1Phase 4<1 mi
LINK-IT: Leveraging vIdeos and commuNity Health worKers to Improve Diabetes OuTcomesN/A<1 mi
Kidney Precision Medicine Project—<1 mi
Transformative Research in Diabetic Nephropathy—<1 mi
TrialNet Pathway to Prevention of T1D—<1 mi
A Study of GNTI-122 in Adults Recently Diagnosed With T1DPhase 1<1 mi
RESET System Pivotal Trial (Rev F)N/A<1 mi
Miro3D Wound Matrix Study for Diabetic Foot Ulcers and Wound HealingN/A<1 mi
Novel Digital Patient-Reported Outcomes Tool for Diabetes ManagementN/A<1 mi
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry Study—<1 mi
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 DiabetesN/A<1 mi
Pregnancy and Postpartum CGM in GDM—<1 mi
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 DiabetesPhase 3<1 mi
Miro3D Wound Matrix for Treatment of Diabetic Foot UlcersN/A<1 mi
Texts for Diabetes Control Among Homeless PersonsN/A<1 mi
Lifestyle Patterns and Glycemic ControlN/A<1 mi
Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione LevelsPhase 1<1 mi
HLA Demographics Study in Adults With Type 1 Diabetes—<1 mi
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 DiabetesPhase 2<1 mi
DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational DiabetesPhase 4<1 mi
PREvention of CardIovascular and DiabEtic kidNey Disease in Type 2 DiabetesPhase 4<1 mi
ED Diabetes Screening and Outpatient Care - Aim 3N/A<1 mi
CGM for the Early Detection and Management of Hyperglycemia in PregnancyN/A<1 mi
Diazoxide Suppression Test P&F StudyPhase 1<1 mi
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes MellitusPhase 2<1 mi
Bionic Pancreas in CFRDPhase 3<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 DiabetesPhase 3<1 mi
CHIME: Comparing Health Interventions for Maternal EquityN/A<1 mi
T1D Pregnancy & Me—<1 mi
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinPhase 3<1 mi
Implementing an Effective Diabetes Intervention Among Low-Income ImmigrantsN/A<1 mi
Graded Insulin Suppression Test P&FPhase 1<1 mi
Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney DiseasePhase 3<1 mi
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)—<1 mi
Real World Evidence Clinical Utility Study of KidneyIntelX—<1 mi
PRenatal and Obstetric Maternal Exposures and ISlet Autoantibodies in Early Life—<1 mi
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational DiabetesPhase 2/3<1 mi
SAINT in Postpartum Depression (PPD)N/A<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II DisorderPhase 2<1 mi
Engage & Connect: A Psychotherapy for Postpartum DepressionN/A<1 mi
A Study of Brenipatide in Adult Participants With Major Depressive DisorderPhase 3<1 mi
Telephone-Based Support Programs for People With EpilepsyN/A<1 mi
Multicenter Study to Assess the Efficacy and Safety of LB-102 in the Treatment of Adult Patients With BP1MDE.Phase 2<1 mi
WellPATH-PREVENT: A Mobile Intervention for Middle-Aged and Older Adults Hospitalized for Suicidal Ideation or AttemptN/A<1 mi
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33N/A<1 mi
Maintenance rTMS for Depression (Maitr-De)N/A<1 mi
Safe Mothers, Safe Children InitiativeN/A<1 mi
A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer SurvivorsPhase 2<1 mi
Neutralizing Interleukin (IL)-6Phase 2<1 mi
Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)N/A<1 mi
Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD)N/A<1 mi
Mindfulness-Based fMRI Neurofeedback for DepressionN/A<1 mi
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric PatientsPhase 3<1 mi
Improving the Mental Health of Home Health AidesN/A<1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)Phase 3<1 mi
DBS for TRD With the Medtronic Percept PCN/A<1 mi
A Digital Intervention for Post-Stroke Depression and Executive DysfunctionPhase 2<1 mi
Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of DepressionPhase 2<1 mi
Biomarker-guided rTMS for Treatment Resistant DepressionPhase 3<1 mi
A Digitally Assisted Risk Reduction Platform for Youth at High Risk for SuicideN/A<1 mi
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive DisorderPhase 3<1 mi
Tele-PROTECT Therapy: Effectiveness, Empowerment, and ImplementationN/A<1 mi
WeCare: A System of Care for Black YouthN/A<1 mi
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)Phase 2<1 mi
ROSE in Sunset ParkN/A<1 mi
Psilocybin With Pimavanserin Compared to Psilocybin Alone for the Treatment of Major Depressive DisorderPhase 2<1 mi
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive DisorderPhase 2<1 mi
Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life SuicidalityN/A<1 mi
Invasive Decoding and Stimulation of Altered Reward Computations in Depression PatientsN/A<1 mi
A Study to Evaluate the Effectiveness of DT-101 in Patients With DepressionPhase 2<1 mi
Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)Phase 2<1 mi
Pattern Separation in Major Depressive DisorderPhase 1<1 mi
Accelerated TMS for Depression and OCDN/A<1 mi
tDCS: Sleep to Mood in Depression (S2M-D)N/A<1 mi
Dominantly Inherited Alzheimer Network (DIAN)—<1 mi
The Effects of Successful OSA Treatment on Memory and AD Biomarkers in Older Adults StudyN/A<1 mi
Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's DiseasePhase 2<1 mi
Aβ Dynamics in LLMDPhase 4<1 mi
Designing Care Management for Hospice Transitions for Persons Living With Advanced DementiaN/A<1 mi
Phase 2 - Rhythmic Light Therapy for Alzheimer's Disease PatientsN/A<1 mi
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationPhase 2/3<1 mi
Late Onset Alzheimer's Disease—<1 mi
Longitudinal Imaging of Microglial Activation in Different Clinical Variants of Alzheimer's DiseasePhase 2<1 mi
Innate Immunity Stimulation Via TLR9 in Early ADPhase 1<1 mi
Longitudinal Early-onset Alzheimer's Disease Study Protocol—<1 mi
Safety Assessment of Leronlimab and Its Effect on Brain Inflammation in Alzheimer's DiseasePhase 2<1 mi
Genetic Studies of Early-onset Dementia—<1 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's DiseasePhase 3<1 mi
Dementia Caregivers' Link to Assistance and ResourcesN/A<1 mi
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic MutationPhase 2/3<1 mi
Triage Survey for Neurology Research Eligibility—<1 mi
Evaluating the Efficacy of the Pain Identification and Communication ToolkitN/A<1 mi
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's DiseaseN/A<1 mi
Early Age-Related Hearing Loss Investigation (EARHLI)N/A<1 mi
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose WeightPhase 3<1 mi
AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaPhase 3<1 mi
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing ChemotherapyPhase 2<1 mi
Weight Loss Study: Genetics and Response to Naltrexone/BupropionPhase 4<1 mi
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)N/A<1 mi
Comparing the Efficacy and Safety of the EndoZip System and Apollo ESG in Obese PatientsN/A<1 mi
AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep ApnoeaPhase 3<1 mi
A Study to Investigate Why Overweight People Regain Weight After Losing Weight in a Behavioral Weight Loss ProgramN/A<1 mi
Endoscopic Bariatric Therapies (EBTs): A Retrospective and Prospective Multicenter Registry—<1 mi
Proof-of-Concept Study Evaluating Total Body Weight, Physical Function & Safety of Enobosarm in Patients Treated With GLP-1 Receptor Agonist, for Weight LossPhase 2<1 mi
The Sleep2BWell TrialN/A<1 mi
Chronic Widespread Pain After Rapid Weight Loss in Non-Hispanic Black and Hispanic/Latino/a/x Adults—<1 mi
Reducing Obesity Using Social Ties ProgramN/A<1 mi
Time Restricted Eating for WeIght LoSs MainTenance-2N/A<1 mi
Randomized Study on Transoral Outlet Reduction and Lifestyle Changes for Weight Regain After Gastric BypassN/A<1 mi
The Peri-OPerative COlchicine to Reduce Negative Events (POPCORN) TrialPhase 4<1 mi
Sudden Unexplained Death in Childhood (SUDC) Registry—<1 mi
Open-label, Dose Escalation Study of Safety and Preliminary Efficacy of TN-401 in Adults With PKP2 Mutation-associated ARVCPhase 1<1 mi
EFS of the DUO System for Tricuspid RegurgitationN/A<1 mi
Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed Field Ablation SystemN/A<1 mi
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)N/A<1 mi
Left vs Left Randomized Clinical TrialN/A<1 mi
ViewFlex X ICE First-in-Human Study—<1 mi
Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)—<1 mi
Physiology-guided vs Angiography-guided Non-culprit Lesion Complete Revascularization for Acute MI & Multivessel DiseaseN/A<1 mi
COMPASSION S3 - Evaluation of the SAPIEN 3 Transcatheter Heart Valve in Patients With Pulmonary Valve DysfunctionN/A<1 mi
Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)N/A<1 mi
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEFPhase 2<1 mi
BIOTRONIK Investigation of the LivIQ Leadless Pacemaker SystemN/A<1 mi
Subclinical Transthyretin Cardiac Amyloidosis in V122I TTR Carriers—<1 mi
Physical Activity and Cognitive Development in Children—<1 mi
BoxX-NoAF Clinical TrialN/A<1 mi
Intravascular Lithotripsy With or Without Rotational Atherectomy for Coronary Calcified Nodule TreatmentN/A<1 mi
Early Feasibility Study (EFS) Evaluating Percutaneous Repair of the Atrial Septum With a Novel PFO Occluder: The PROTEA-PFO StudyN/A<1 mi
One-Month DAPT in CABG PatientsPhase 3<1 mi
The JenaValve ALIGN-AR LVAD RegistryN/A<1 mi
Impella Reverse Remodeling in End-Stage Heart Failure—<1 mi
Psychosocial Support for Patients With Takotsubo SyndromeN/A<1 mi
Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry—<1 mi
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Phase 3<1 mi
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina IIN/A<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - WomenPhase 3<1 mi
Pericardiotomy in Cardiac SurgeryN/A<1 mi
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight InfantsN/A<1 mi
His-Bundle Corrective Pacing in Heart FailureN/A<1 mi
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEmN/A<1 mi
Enhanced Nutritional Optimization in LVAD TrialN/A<1 mi
Medtronic Cardiac Surgery PMCF Registry—<1 mi
CTSN Embolic Protection TrialN/A<1 mi
An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement SystemN/A<1 mi
Phase 2/3 Study of KPL-387 in Recurrent PericarditisPhase 2/3<1 mi
Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation—<1 mi
Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ)Phase 3<1 mi
Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery LesionsN/A<1 mi
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial HypercholesterolemiaPhase 3<1 mi
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)Phase 3<1 mi
Danon Disease Natural History Study—<1 mi
The TRICURE EFS StudyN/A<1 mi
Cardiogenic Shock Working Group Registry—<1 mi
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular HypertrophyPhase 2<1 mi
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs—<1 mi
ARIADNE Clinical TrialN/A<1 mi
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)N/A<1 mi
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral AnticoagulationN/A<1 mi
The Half Moon Transcatheter Mitral Valve Repair (TMVr) Pilot StudyN/A<1 mi
CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry—<1 mi
Trisol System EFS StudyN/A<1 mi
Imaging Coronary Microvascular Dysfunction (CMD) StudyN/A<1 mi
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery LesionsN/A<1 mi
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment—<1 mi
Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp SystemPhase 2<1 mi
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)N/A<1 mi
SELUTION 4 De Novo Small Vessel IDE TrialN/A<1 mi
Implementation of IVS3 for Upper Limb Motor RecoveryN/A<1 mi
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor—<1 mi
The CONFORM Pivotal TrialN/A<1 mi
Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)N/A<1 mi
Cephea Early Feasibility StudyN/A<1 mi
DELINEATE-Prospective—<1 mi
Cardiac Sarcoidosis Randomized TrialPhase 3<1 mi
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)Phase 3<1 mi
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)N/A<1 mi
Reducing Risk for Infective EndocarditisN/A<1 mi
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation PatientsN/A<1 mi
Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)N/A<1 mi
AltaValve Pivotal TrialN/A<1 mi
A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)N/A<1 mi
The Fourth Left Atrial Appendage Occlusion StudyN/A<1 mi
Use of Adenosine to Determine the Electrophysiological Mechanism of Premature Ventricular ContractionsPhase 4<1 mi
Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three FractionsN/A<1 mi
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart DiseaseN/A<1 mi
PARTNER 3 Trial - Aortic Valve-in-ValveN/A<1 mi
PRIMARY Ancillary SubstudyN/A<1 mi
Defining the Basis of Fibromuscular Dysplasia (FMD)—<1 mi
Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease TreatmentN/A<1 mi
Heart Attack Research Program: Platelet Sub-Study (HARP)—<1 mi
CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal StudyN/A<1 mi
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic CardiomyopathyPhase 2<1 mi
FORWARD CAD IDE StudyN/A<1 mi
The Prevent Coronary Artery Disease TrialPhase 3<1 mi
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3<1 mi
A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial FibrillationN/A<1 mi
Transition to KPL-387 Monotherapy Dosing & Administration StudyPhase 2<1 mi
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and IIIN/A<1 mi
A Pragmatic Clinical Trial of the WE BEAT Well-Being Education Program in Adolescent Congenital Heart Disease: WE BEAT CHD StudyN/A<1 mi
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2Phase 3<1 mi
Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse—<1 mi
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)—<1 mi
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)—<1 mi
Trial of the F2 Filter and Delivery System for Embolic Protection During TAVRN/A<1 mi
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart FailureN/A<1 mi
A Multicenter Trial Assessing the Impact of Lipoprotein(a) Lowering With Pelacarsen (TQJ230) on the Progression of Calcific Aortic Valve StenosisPhase 2<1 mi
TVMR With the INNOVALVE System Trial - Early Feasibility StudyN/A<1 mi
Intestinal Microbiota Transplantation in Patients With Chronic Heart FailurePhase 1<1 mi
Transfusion Requirements in Younger Patients Undergoing Cardiac SurgeryN/A<1 mi
J-Valve Transfemoral Pivotal StudyN/A<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomesPhase 4<1 mi
TTVR Early Feasibility StudyN/A<1 mi
mHealth-CArdiac REhabilitation for INOCAN/A<1 mi
LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic ConditionsPhase 4<1 mi
A Study of Vosoritide in Children With Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone TreatmentPhase 2<1 mi
Use of ReDS Technology in Patients With Acute Heart FailureN/A<1 mi
CardioFocus HeartLight Post-Approval StudyN/A<1 mi
Skin Pigment/Pulse Oximeter in Congenital Heart Disease (CHD)—<1 mi
Hospital Airway Resuscitation TrialN/A<1 mi
Exercise Activity Intervention With Sensor-Based Engagement in Patients With Atrial FibrillationN/A<1 mi
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).N/A<1 mi
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias—<1 mi
Safety and Effectiveness of Pulmonary Vein isOLation And posterioR Wall Ablation wIth pulSed Field Energy in Patients With Paroxysmal and Persistent AFN/A<1 mi
The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)—<1 mi
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease—<1 mi
Improving the Heart Health of Home Health AidesN/A<1 mi
Pediatric Influence of Cooling Duration on Efficacy in Cardiac Arrest Patients (P-ICECAP)N/A<1 mi
ANDREAS Registry (Assessment of Novel Drug-coated Balloon Revascularization: Effectiveness, Angiographic Outcomes, and Safety)—<1 mi
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With CardiomyopathyPhase 3<1 mi
Assessment of Safety and Accuracy of the Microtech System in Patients Undergoing Left Ventricular Assist Device ImplantationN/A<1 mi
PULSED AF Post-Approval Study—<1 mi
EFS of the CardioMech MVRSN/A<1 mi
The CardioClip StudyN/A<1 mi
Slow Heart Registry of Fetal Immune-mediated High Degree Heart Block—<1 mi
Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's AtaxiaPhase 1<1 mi
Natural History Study in Pediatric Patients With MYBPC3 Mutation-associated Cardiomyopathy—<1 mi
Beta-blocker Administration for Cardiomyocyte DivisionPhase 1<1 mi
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)N/A<1 mi
Prevail Global StudyN/A<1 mi
Registry of Patients With Takotsubo Syndrome—<1 mi
Use of Phenylephrine for Assessment of Mitral Regurgitation SeverityPhase 1/2<1 mi
Impact of Bromocriptine on Clinical Outcomes for Peripartum CardiomyopathyPhase 4<1 mi
Aspirin and Hemocompatibility Events in Chronic Advanced Heart Failure Patients With Assist DevicePhase 4<1 mi
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)Phase 2/3<1 mi
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic CardiomyopathyPhase 3<1 mi
Quantifying New Heart Muscle CellsN/A<1 mi
Analysis of Lumbar Spine Stenosis Specimens for Identification of Transthyretin Cardiac Amyloidosis—<1 mi
The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative DeliriumPhase 3<1 mi
AMEND TS Early Feasibility StudyN/A<1 mi
The Relationship Between Blood Flow Readings During Surgery and How Well the Graft Stays Open and How Patients Recover Afterward in Coronary Artery Bypass Graft SurgeryN/A<1 mi
Improving TRansitions ANd OutcomeS for Heart FailurE Patients in Home Health CaRe (I-TRANSFER-HF)N/A<1 mi
REvascularization CHoices Among Under-Represented Groups Evaluation: The RECHARGE Trial - MinoritiesPhase 3<1 mi
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive ProcedureN/A<1 mi
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart FailureN/A<1 mi
Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension SystemN/A<1 mi
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and InflammationPhase 3<1 mi
The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) PatientsPhase 4<1 mi
A Prospective Research Investigation of Ischemia Using MCG—<1 mi
An Open-Label Pilot Study of VTX2735 in Recurrent PericarditisPhase 2<1 mi
TeleheartCR vs. Clinic-Based Cardiac Rehabilitation After Acute Coronary SyndromeN/A<1 mi
REPRESENT-PF Registry—<1 mi
Evaluating the Relationship Between Skin Color and Pulse Oximeter Accuracy in Children—<1 mi
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)N/A<1 mi
A Patient Activation Approach to Implementing Depression Treatment in Cardiac PatientsN/A<1 mi
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionPhase 3<1 mi
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEFPhase 3<1 mi
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome—<1 mi
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM—<1 mi
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart FailureN/A<1 mi
A Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of PKN605 in Participants With Atrial FibrillationPhase 2<1 mi
Enhanced Valves Interventions and Safe AI Generated End Results—<1 mi
Rectus Sheath Block in Cardiac SurgeryN/A<1 mi
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve ReplacementN/A<1 mi
Post-CA Neuroprotection With MagnesiumPhase 1<1 mi
Characterization of the Cardiac Phenotype of Friedreich's Ataxia (FRDA)—<1 mi
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2Phase 3<1 mi
Asthma Symptom Perception StudyN/A<1 mi
Cost Effective Air Filtration Intervention in Low-Income Housing to Reduce Asthma MorbidityN/A<1 mi
Biologics And Clinical Immunology Cohort at Sinai—<1 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)—<1 mi
Allergy and Immunology Natural History Study—<1 mi
Protocol CAUSE-03 / CHEETAH—<1 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaPhase 2<1 mi
Cannabidiol (CBD) in Pain Reduction for Knee OsteoarthritisPhase 2/3<1 mi
Impact of Bone-Marrow Aspirate Injections in Knee ArthroscopyN/A<1 mi
Osteochondral Allograft in the Surgical Treatment of Basal Joint ArthritisN/A<1 mi
Study on Basal Joint Arthritis Prospective—<1 mi
Preventing Injured Knees From osteoArthritis: Severity OutcomesPhase 2<1 mi
Return to Golf After Orthopaedic Surgery—<1 mi
The KinematX Midcarpal Total Wrist Arthroplasty Registry—<1 mi
Study of Dapansutrile Tablets in Subjects With an Acute Gout FlarePhase 2/3<1 mi
Guselkumab vs Golimumab in PsA TNF Inadequate Responder PatientsPhase 3<1 mi
Multi-Center PAMPA StudyPhase 4<1 mi
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.Phase 3<1 mi
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis—<1 mi
RA-PRO PRAGMATIC TRIALPhase 3<1 mi
Exactech Shoulder Post Market Clinical Follow-up Study—<1 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Knee OsteoarthritisEarly 1<1 mi
Navio Robotic Versus Conventional Total Knee ArthroplastyN/A<1 mi
Persona MC vs PS RCT With ROSAN/A<1 mi
Oral Nutritional Optimization in Total Joint ArthroplastyN/A<1 mi
Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutPhase 4<1 mi
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)Phase 1/2<1 mi
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainPhase 3<1 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or AdalimumabPhase 3<1 mi
Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-BeingN/A<1 mi
Safety and Feasibility of Umbilical Cord Wharton's Jelly Allograft Injections for Lumbar PainPhase 1<1 mi
MOTION Clinical TrialN/A<1 mi
Closed Loop Oxygen Control in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Nasal High Flow in the HospitalN/A<1 mi
Lung Microbiome and Inflammation in Early COPD—<1 mi
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)Phase 1<1 mi
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)Phase 3<1 mi
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies—<1 mi
SPIROMICS Study of Early COPD Progression (SOURCE)—<1 mi
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPDPhase 2<1 mi
Comprehensive Patient-Centered Home-based Care Coaching for COPD Self-managementN/A<1 mi
Evaluation Of The Lung Microbiome In NTM Bronchiectasis—<1 mi
PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.N/A<1 mi
RE104 Safety and Efficacy Study in Generalized Anxiety DisorderPhase 2<1 mi
Connectomic Deep Brain Stimulation for Obsessive Compulsive DisorderN/A<1 mi
Computer - Based Treatment for Social Anxiety DisorderN/A<1 mi
Prediction of Anxiety and Memory StateN/A<1 mi
Study of Cannabidiol and Neuroimaging on StressPhase 1/2<1 mi
Stress and Anxiety Effects on ValuationN/A<1 mi
Virtual Reality for Pain Control in US-Guided Obstetric Needle ProceduresN/A<1 mi
Assessment of Music Experiences in Navigating Depression Part 2N/A<1 mi
Psilocybin-Assisted Therapy for Intergenerational TraumaPhase 2<1 mi
Precision Analytic Research Methods in OCDN/A<1 mi
Feasibility and Acceptability of a Novel Cognitive Behavioral Skills Mobile App for Pregnant and Postpartum IndividualsN/A<1 mi
Personalized Mobile Cognitive Behavioral Therapy ApplicationN/A<1 mi
Prevention of Psychological Health Problems Via Integrated Operational SupportN/A<1 mi
Mobile CBT for Middle Aged and Older AdultsN/A<1 mi
An Exploratory Study Examining Biopsychosocial Markers of Anxiety and Depression—<1 mi
Pramipexole to Enhance Social ConnectionsPhase 2<1 mi
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer SurvivorsPhase 4<1 mi
Biomarkers for ExerciseN/A<1 mi
Anxiety During Abstinence in AUDEarly 1<1 mi
Virtual Reality for Pain Management in Burn PatientsN/A<1 mi
Neural Circuit Effects of Ketamine in DepressionPhase 4<1 mi
Harlem Strong Mental Health CoalitionN/A<1 mi
Helping Adults With Obsessive-Compulsive Disorder Succeed at WorkN/A<1 mi
ERP to Improve Functioning in Veterans With OCDN/A<1 mi
Brief Interventions for Coping with DistressN/A<1 mi
Mobile Cognitive Behavioral Therapy for StrokeN/A<1 mi
Triage Survey for Psychiatry Research Eligibility—<1 mi
Readiness and Progress in Emotion Regulation TherapyN/A<1 mi
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3<1 mi
A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)Phase 2<1 mi
Parkinson's Disease Biomarkers in Nerve Cells in the Gut—<1 mi
Effects of Transcranial Focused Ultrasound Stimulation (tFUS) on Neurological and Cognitive Outcomes in Parkinson's DiseaseN/A<1 mi
This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.Phase 1/2<1 mi
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Have Parkinson's DiseasePhase 3<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications—<1 mi
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's DiseasePhase 2<1 mi
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor FluctuationsPhase 2<1 mi
Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's DiseaseEarly 1<1 mi
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease—<1 mi
Rehabilitation of Airway Protection in Parkinson's DiseasePhase 2<1 mi
Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's PatientsN/A<1 mi
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/3<1 mi
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—<1 mi
A Study of Buntanetap in Participants With PDPhase 2/3<1 mi
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's DiseasePhase 1/2<1 mi
Drug Discovery for Parkinson's With Mutations in the GBA Gene—<1 mi
Autoimmune Features of Neurodegenerative Disorders—<1 mi
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus ErythematosusPhase 1<1 mi
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus ErythematosusPhase 1/2<1 mi
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)—<1 mi
Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder ArthroplastyPhase 2<1 mi
Safety and Efficacy of ONT01 in LupusEarly 1<1 mi
VIBRANT: VIB4920 for Active Lupus NephritisPhase 2<1 mi
Alnuctamab for Refractory SLE (LATTE Study)Phase 1<1 mi
A Phase 1/2 Study of NKX019 in Subjects With Autoimmune Disease (Ntrust-1)Phase 1/2<1 mi
IMPACT Study: IMProve Pregnancy in APS With Certolizumab TherapyPhase 2<1 mi
Effects of Stopping Hydroxychloroquine in Elderly Lupus DiseasePhase 3<1 mi
Lupus Landmark Study: A Prospective Registry and Biorepository—<1 mi
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric ParticipantsPhase 3<1 mi
Safety of the Herpes Zoster Subunit Vaccine in LupusPhase 4<1 mi
A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132Phase 4<1 mi
A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in Participants With Active SLE Despite Immunosuppressants (Breakfree-SLE)Phase 2<1 mi
A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLEPhase 1/2<1 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)Phase 1<1 mi
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune DiseasesPhase 2<1 mi
The Pediatric Lupus Nephritis Mycophenolate Mofetil (PLUMM) StudyPhase 2<1 mi
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune DiseasePhase 1<1 mi
Repository of Novel Analytes Leading to Autoimmune, Inflammatory and Diabetic Nephropathies (RENAL AID)—<1 mi
PHENOGENE-1A (Cromolyn) Treatment in Patients With Mild to Moderate ALSPhase 2<1 mi
Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPhase 4<1 mi
Effect of Cooling on Balance Performance in Multiple Sclerosis—<1 mi
Genes and Environment in Multiple Sclerosis—<1 mi
Home-Based Transcranial Direct Current Stimulation (tDCS) for Depression in Multiple Sclerosis (MS)Phase 2<1 mi
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of UblituximabPhase 3<1 mi
A Palliative Care Model Impact on Knowledge and AttitudesN/A<1 mi
NYSCF Scientific Discovery Biobank—<1 mi
Vancomycin Study in Multiple Sclerosis (MS)Phase 1<1 mi
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune DisordersPhase 1<1 mi
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesPhase 1<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Phase 1<1 mi
Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders—<1 mi
Eccentric Exercise and Fatigue in Multiple Sclerosis—<1 mi
A Study of AZD0120 in Autoimmune DiseasesPhase 1<1 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 1<1 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 3<1 mi
A Study of the MIND Diet for Persons With Multiple SclerosisN/A<1 mi
Task Specific Training for Advanced Multiple SclerosisN/A<1 mi
TSC Biosample Repository and Natural History Database—<1 mi
Study of COYA 302 for the Treatment of ALSPhase 2<1 mi
Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple SclerosisPhase 2<1 mi
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerPhase 1<1 mi
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast CancerPhase 1<1 mi
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)Phase 3<1 mi
Leflunomide in Patients With PTEN-Altered Advanced Solid Malignancies and HER2 Negative Breast CancerPhase 1<1 mi
A Study of Multiparametric MRI and pHLIP® ICG in Breast Cancer Imaging During SurgeryPhase 1/2<1 mi
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You—<1 mi
Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast CancerPhase 4<1 mi
Study of INCB123667 in Subjects With Advanced Solid TumorsPhase 1<1 mi
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast CancerPhase 2<1 mi
Pancreatic Cancer Genetics—<1 mi
IMPACT Trial: Intervention to iMProve AdherenCe EquitablyN/A<1 mi
Opioid Dispensing Device for Post-Operative Pain in Cancer PatientsN/A<1 mi
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer—<1 mi
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense BreastsN/A<1 mi
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast CancerPhase 2<1 mi
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsPhase 1<1 mi
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast CancerPhase 2<1 mi
Two Versus One Week Breast Radiotherapy (RT)Phase 3<1 mi
Breast Cancer Implementation Science Study With Educational InterventionN/A<1 mi
Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) MutationPhase 1<1 mi
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)Phase 2/3<1 mi
Women Informed to Screen Depending on Measures of Risk (Wisdom Study)N/A<1 mi
Generation of Heart Muscle Cells From Blood or Skin Cells of Breast Cancer Patients—<1 mi
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 AlterationPhase 1/2<1 mi
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)N/A<1 mi
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients—<1 mi
Converting HR+ Breast Cancer Into an Individualized VaccinePhase 2<1 mi
A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania—<1 mi
Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast CancerPhase 1<1 mi
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced CancerN/A<1 mi
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton TherapyPhase 3<1 mi
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaPhase 1<1 mi
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated TumorsN/A<1 mi
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida—<1 mi
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad OncN/A<1 mi
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid MalignanciesPhase 1/2<1 mi
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)Phase 3<1 mi
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles—<1 mi
Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)Phase 1/2<1 mi
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)Phase 3<1 mi
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast CancerEarly 1<1 mi
Gene Therapy for HER-Positive Cancer (SENTRY-HER2)Phase 1/2<1 mi
A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCsPhase 1<1 mi
A Study of Changes in Ki67 Expression in People With Breast Cancer Receiving Endocrine Therapy Before SurgeryN/A<1 mi
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)—<1 mi
A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast CancerPhase 3<1 mi
A Study of LY4337713 in Participants With FAP-Positive Solid TumorsPhase 1<1 mi
A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast CancerPhase 2<1 mi
Enhancing Access to Supportive Services for Women of Color With Metastatic Breast CancerN/A<1 mi
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerPhase 3<1 mi
Tirzepatide's Role in Postmenopausal HR+ Breast Cancer SurvivorsPhase 4<1 mi
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)Phase 3<1 mi
Clinical Validation of Early Detection Blood Test for Universal Large-scale Breast Cancer Screening—<1 mi
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast CancerPhase 3<1 mi
A Study of Tetrathiomolybdate (TM) Plus CapecitabinePhase 1/2<1 mi
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer PatientsPhase 1/2<1 mi
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerPhase 3<1 mi
Elacestrant in Advanced Triple Positive Breast CancerPhase 1/2<1 mi
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)Phase 3<1 mi
Abemaciclib in Combination With Bicalutamide for Androgen Receptor-positive, HER2-negative Metastatic Breast CancerPhase 1/2<1 mi
A Study of LY4257496 in Participants With Cancer (OMNIRAY)Phase 1<1 mi
Optimizing Surgical Decisions in Young Adults With Breast CancerN/A<1 mi
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast CancerN/A<1 mi
ORION-1: Study of AVZO-023 as a Single Agent and in Combination With AVZO-021, and/or Endocrine Therapy in Advanced Solid TumorsPhase 1/2<1 mi
Study of AVZO-021 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
Medical Imaging and Thermal Treatment for Breast Tumors Using Harmonic Motion Imaging (HMI)N/A<1 mi
Exercise Therapy to Improve Cardiovascular Health in Post-Menopausal Women After Treatment for Early Stage Breast CancerN/A<1 mi
Combined Immunotherapies in Metastatic ER+ Breast CancerPhase 2<1 mi
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsPhase 3<1 mi
Breast Elasticity Imaging During Neoadjuvant ChemotherapyN/A<1 mi
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as TreatmentPhase 2<1 mi
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialPhase 2<1 mi
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid MalignanciesPhase 1/2<1 mi
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has SpreadPhase 1/2<1 mi
A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine TherapyPhase 3<1 mi
A Study of Emiltatug Ledadotin (Emi-Le) in Participants With Solid TumorsPhase 1/2<1 mi
First in Human Study of TUB-030 in Patients With Advanced Solid TumorsPhase 1/2<1 mi
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid TumorsPhase 1<1 mi
A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid TumoursPhase 1<1 mi
The Cancer of the Pancreas Screening-5 CAPS5)StudyPhase 3<1 mi
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 ExpressionPhase 1/2<1 mi
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid TumorsPhase 1/2<1 mi
A Study of Multiple Therapies in Biomarker-selected Participants With Resectable Stages IB-III Non-small Cell Lung Cancer (NSCLC)Phase 2<1 mi
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet®Phase 2<1 mi
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine CancersPhase 2<1 mi
Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic DisordersPhase 2<1 mi
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC PatientsPhase 3<1 mi
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPhase 1/2<1 mi
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung CancerPhase 1/2<1 mi
Ladarixin With Sotorasib in Advanced NSCLCPhase 1<1 mi
Empathic Communication Skills (ECS) TrainingN/A<1 mi
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid TumorsPhase 1<1 mi
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.Phase 2/3<1 mi
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)Phase 1/2<1 mi
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS MutationsPhase 1<1 mi
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD MutationsPhase 3<1 mi
A Study of LY4050784 in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor MalignanciesPhase 1/2<1 mi
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLCPhase 3<1 mi
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)Phase 3<1 mi
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung CancerPhase 3<1 mi
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)Phase 3<1 mi
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56Phase 1/2<1 mi
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid TumorsPhase 1<1 mi
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D MutationPhase 1<1 mi
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung CancerPhase 1/2<1 mi
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)Phase 1<1 mi
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid TumorsPhase 1<1 mi
Study to Assess Safety, Tolerability and Activity of DSB2455 in Participants With Advanced MalignanciesPhase 1<1 mi
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)Phase 2/3<1 mi
A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLCPhase 2<1 mi
DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung CancerPhase 2<1 mi
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)Phase 1<1 mi
M0324 as Monotherapy and in Combination With Pembrolizumab or Chemotherapy in Participants With Selected Advanced Solid TumorsPhase 1<1 mi
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid TumorsPhase 1<1 mi
Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon MutationsPhase 3<1 mi
A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 MutationsPhase 1/2<1 mi
A Study of Mental Health Care in People With CancerN/A<1 mi
Inpatient Capture: A Mixed Methods Study to Develop an Inpatient Lung Cancer Screening Program in a Safety Net Hospital.N/A<1 mi
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)Phase 3<1 mi
A Multicenter Study in Bronchoscopy Combining Stimulated Raman Histology With Artificial Intelligence for Rapid Lung Cancer Detection - The ON-SITE Study—<1 mi
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung CancerPhase 1<1 mi
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant TumorsPhase 1/2<1 mi
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 3<1 mi
Testing Tumor Tissue and Blood to Help Select Personalized Treatments for Patients With Suspected Lung Cancers—<1 mi
Trial Investigating Visugromab in Combination With Immunochemotherapy in 1L Treatment of Participants With Metastatic NSCLCPhase 2<1 mi
A Phase I/II Study of VLS-1488 in Subjects With Advanced CancerPhase 1/2<1 mi
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive MalignanciesPhase 1/2<1 mi
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic TumorsPhase 1<1 mi
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing—<1 mi
A Study of the Oral EGFR Inhibitor PLB1004 in Non-Small Cell Lung CancerPhase 1<1 mi
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung CancerPhase 3<1 mi
A Study of Navlimetostat (BMS-986504) in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)Phase 2<1 mi
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 ExpressionPhase 1/2<1 mi
Genomic and Methylation Markers in SCLC and LCNEC for Chemo-Immunotherapy Resistance Prediction (STRATUS)—<1 mi
Phase Ib Study of the Safety of T-DXd and Immunotherapy Agents With and Without Chemotherapy in Advanced or Metastatic HER2+, Non-squamous NSCLCPhase 1<1 mi
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)Phase 1<1 mi
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers—<1 mi
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid TumorsPhase 1<1 mi
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C MutationPhase 1/2<1 mi
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)Phase 3<1 mi
Confocal Laser Endomicroscopy VERificationN/A<1 mi
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid TumorsPhase 1/2<1 mi
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H MutationPhase 1<1 mi
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid TumorsPhase 1/2<1 mi
Tier - Palliative Care For Patients With Advanced Heart Failure or CancerN/A<1 mi
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLCPhase 1/2<1 mi
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid TumorsPhase 1<1 mi
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced CancersPhase 1<1 mi
A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung CancerPhase 1<1 mi
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCPhase 1/2<1 mi
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and LymphomasPhase 1/2<1 mi
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid TumorsPhase 1<1 mi
GEMINI-NSCLC: NSCLC Biomarker Study—<1 mi
BBO-11818 in Adult Subjects With KRAS Mutant CancerPhase 1<1 mi
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid TumorsPhase 1<1 mi
Safety and Tolerability of IPH4502 in Patients With Advanced Solid TumorsPhase 1<1 mi
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCPhase 3<1 mi
Patient-Generated Health Data Collection During Chemoradiotherapy for Lung Cancer—<1 mi
A Study of PRMT5 Inhibitor BAY 3713372 in Participants With MTAP-deleted Solid TumorsPhase 1/2<1 mi
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Solid TumorsPhase 1<1 mi
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia—<1 mi
A Study of LY4170156 in Participants With Selected Advanced Solid TumorsPhase 1<1 mi
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC PatientsPhase 1/2<1 mi
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)Phase 1/2<1 mi
A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic AlterationsPhase 1/2<1 mi
Comprehensive Outcomes for After Cancer HealthN/A<1 mi
A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung CancerPhase 1<1 mi
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)Phase 3<1 mi
Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLCPhase 2<1 mi
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsPhase 2<1 mi
Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid TumorsPhase 1/2<1 mi
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP LossPhase 1/2<1 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 2<1 mi
Open-Label Study of BBO-10203 in Subjects With Advanced Solid TumorsPhase 1<1 mi
Phase II Trial of Lung ChemoemobolizationPhase 2<1 mi
A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung CancerPhase 1/2<1 mi
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid MalignanciesPhase 1/2<1 mi
Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line TreatmentPhase 2<1 mi
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)—<1 mi
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking AbilityPhase 3<1 mi
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLCPhase 2<1 mi
Safety and Efficacy of OBX-115 in Advanced Solid TumorsPhase 1/2<1 mi
A Phase 1/2 Study of TRI-611 in ALK-Positive NSCLCPhase 1/2<1 mi
Study of RET Inhibitor TAS0953/HM06 in Patients With Advanced Solid Tumors With RET Gene AbnormalitiesPhase 1/2<1 mi
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)Phase 1<1 mi
Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer—<1 mi
Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid TumorsPhase 1<1 mi
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsPhase 1<1 mi
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid TumorsPhase 1/2<1 mi
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell CarcinomasPhase 1<1 mi
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLCPhase 1/2<1 mi
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid TumorsPhase 1/2<1 mi
A Study of LY4175408 in Participants With Advanced CancerPhase 1<1 mi
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)Phase 1/2<1 mi
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyN/A<1 mi
Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other CancersPhase 1/2<1 mi
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerPhase 2<1 mi
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor TypesPhase 1/2<1 mi
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)Phase 3<1 mi
Multilevel Intervention for Precision OncologyN/A<1 mi
Lung Cancer Biomarkers and Screening—<1 mi
Pembrolizumab for Advanced NSCLC and PS 2-3Phase 2<1 mi
A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung CancerPhase 1/2<1 mi
MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid TumorsPhase 1<1 mi
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsPhase 2<1 mi
A Long-term Extension Study of PCI-32765 (Ibrutinib)Phase 3<1 mi
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%Phase 3<1 mi
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RASPhase 1/2<1 mi
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)Phase 1/2<1 mi
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerPhase 3<1 mi
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung CancerPhase 1/2<1 mi
A Study of SIPLIZUMAB in AILD and LT PatientsPhase 1<1 mi
Study of Choline Chloride for Injection in Adolescent and Adult Patients With Intestinal Failure Receiving Long Term Parenteral SupportPhase 2/3<1 mi
TReatment for ImmUne Mediated PathopHysiologyPhase 2<1 mi
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney InjuryPhase 2<1 mi
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta VirusPhase 1/2<1 mi
Adaptability of an Undetectable = Untransmissible Model for HBV—<1 mi
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs—<1 mi
Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin ProteinPhase 3<1 mi
Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)—<1 mi
Evaluating Alcohol Use in Alcoholic Liver Disease—<1 mi
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United StatesPhase 2<1 mi
HepB mAb19 in Individuals With Chronic Hepatitis B InfectionPhase 1<1 mi
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASHPhase 3<1 mi
A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)Phase 2<1 mi
Effect of Insulin Lowering on LipogenesisPhase 1<1 mi
PiMZ Longitudinal Cohort (PiMZ Logic)—<1 mi
Affect of Melatonin on Sleep and Cognition in CirrhosisN/A<1 mi
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)—<1 mi
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).Phase 2<1 mi
Study to Learn About the Safety of Fazirsiran and if it Can Help People With Alpha-1 Antitrypsin Liver Disease With Mild Liver Scarring (Fibrosis)Phase 3<1 mi
A Prospective Database of Infants With Cholestasis—<1 mi
A Study Observing the Long-term, Effectiveness and Safety of Odevixibat (Bylvay) in Patients With Alagille Syndrome (ALGS) Who Are Receiving Ongoing Treatment—<1 mi
Liver Transplant CGM—<1 mi
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASHPhase 2<1 mi
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver DiseasePhase 2<1 mi
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASHPhase 3<1 mi
High Fructose Diet, the Gut Microbiome, and Metabolic HealthN/A<1 mi
Diet and Meal Timing in Patients With Metabolic Dysfunction Associated Steatoic Liver DiseaseN/A<1 mi
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIVPhase 2<1 mi
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This ConditionPhase 2<1 mi
An Open-label Study to Investigate ECUR-506 in Male Babies Less Than 9 Months of Age With Neonatal Onset OTC DeficiencyPhase 1/2<1 mi
Project I Test: Implementing HIV Testing in Opioid Treatment ProgramsN/A<1 mi
RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)Phase 2<1 mi
Functional Assessment in Liver Transplantation—<1 mi
Human Models of Selective Insulin Resistance: Alpelisib, Part IPhase 1<1 mi
Longitudinal Study of the Porphyrias—<1 mi
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)Phase 2<1 mi
Identification of Acute Intermittent Porphyria Modifying Genes—<1 mi
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASHPhase 3<1 mi
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASHPhase 3<1 mi
A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary CholangitisPhase 3<1 mi
Persuasive Health Communication Intervention for HIV/HCVN/A<1 mi
Study to Evaluate the Safety and Efficacy of Larsucosterol in Participants With Alcohol-associated Hepatitis (AH)Phase 3<1 mi
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated CirrhosisPhase 3<1 mi
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)N/A<1 mi
Gene Therapy for Alpha 1- Antitrypsin DeficiencyPhase 1<1 mi
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaPhase 1<1 mi
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid TumorsPhase 1/2<1 mi
Atezolizumab and Bevacizumab in Combination With Y^90 Radioembolization in HCC for Liver TransplantPhase 4<1 mi
FOG-001 in Locally Advanced or Metastatic Solid TumorsPhase 1/2<1 mi
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid MalignanciesPhase 1<1 mi
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCCPhase 1/2<1 mi
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and ChemotherapyPhase 3<1 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)Phase 1<1 mi
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)Phase 2<1 mi
HOPE Against Cancer Recurrence in HCCPhase 4<1 mi
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsPhase 1<1 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)Phase 1/2<1 mi
A Study of ZW251 in Participants With Advanced Solid TumorsPhase 1<1 mi
Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT TrialPhase 3<1 mi
Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate RetreatmentPhase 2/3<1 mi
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRIN/A<1 mi
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular CarcinomaPhase 1/2<1 mi
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)—<1 mi
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
Testing the Combination of the Anticancer Drug Durvalumab With Chemotherapy (Gemcitabine and Cisplatin) at Improving Outcomes for High-Risk Resectable Liver Cancer Before SurgeryPhase 2<1 mi
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine RegimenPhase 3<1 mi
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation—<1 mi
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaPhase 1<1 mi
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway AberrationsPhase 1<1 mi
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid TumorsPhase 1/2<1 mi
Brodalumab in the Treatment of Immune-Related Adverse EventsPhase 1<1 mi
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid TumorsPhase 2<1 mi
The Dragon PLC Trial (DRAGON-PLC)N/A<1 mi
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid TumorPhase 1<1 mi
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid TumorsPhase 1/2<1 mi
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver MetastasesPhase 2<1 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesPhase 34 mi
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatidePhase 24 mi
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.Phase 24 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPhase 34 mi
A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMPhase 34 mi
First-in-human Study of 7MW4911 in GI CancerPhase 1/24 mi
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid MalignanciesPhase 14 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With DiabetesN/A4 mi
Targeted Genomic Analysis of Blood and Tissue Samples From Patients With Cancer—4 mi
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)Phase 24 mi
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal CancerPhase 24 mi
Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 TargetedPhase 24 mi
ATATcH Alternating Treatment Plans for Advanced CancerPhase 24 mi
DPYD Pharmacogenomics and Fluoropyrimidine (FP) Dose-AdjustmentPhase 44 mi
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)Phase 2/34 mi
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerPhase 24 mi
Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung CancerPhase 24 mi
SuperSaturated Oxygen Comprehensive Observational Registry—4 mi
Innovations in Genicular Outcomes Registry—4 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaPhase 34 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA TreatmentPhase 35 mi
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled CorticosteroidsPhase 25 mi
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants—5 mi
Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety DisorderPhase 25 mi
A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 35 mi
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])Phase 35 mi
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos StudyPhase 25 mi
SilverCloud as a School-Based Intervention for Vulnerable YouthN/A5 mi
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)Phase 35 mi
A Randomized Study of Azetukalner Versus Placebo in Major Depressive DisorderPhase 35 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-2)Phase 35 mi
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety DisorderPhase 25 mi
A Randomized Study of Azetukalner Versus Placebo in Depressive Episodes Associated With Bipolar I or II Disorder (Bipolar Depression)Phase 35 mi
Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders—5 mi
Bearing nsPVA Embolization for Uterine Artery Embolization (BETTER-UAE)—5 mi
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)Phase 35 mi
Pilot Trial of Spiritual Care Interventions for Patients With CancerN/A5 mi
In-Person Lifestyle Program for Black Adolescent Girls at Risk for Type 2 DiabetesN/A5 mi
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes MellitusPhase 35 mi
Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.—5 mi
Triage Survey for Cardiovascular, Obesity, and Related Endocrine Trial Eligibility—5 mi
ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant ResponsePhase 25 mi
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using SolriamfetolPhase 35 mi
Tracking Results of Ablations to Combat AF Registry Generation 2—5 mi
Comparative Effectiveness of Carvedilol Versus Metoprolol Succinate in Heart Failure Patients With an Implantable Cardioverter DefibrillatorPhase 45 mi
BREATHE: An Efficacy-implementation Trial Among Black Adults With Uncontrolled AsthmaN/A5 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponsePhase 35 mi
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout ParticipantsPhase 25 mi
ConsideRAte Study - Splenic Stimulation for RAN/A5 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPhase 35 mi
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPDPhase 25 mi
A Study of NTX-1472 in Social Anxiety DisorderPhase 25 mi
Testing Adapted Self-Help Plus (SH+) for Stress and Well-Being in International Students at a U.S. UniversityN/A5 mi
Nebulized Ketamine for the Treatment of Major Depressive DisorderPhase 35 mi
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety DisorderPhase 25 mi
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)Phase 45 mi
Mobile Health for Adherence in Breast Cancer PatientsN/A5 mi
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPhase 35 mi
Efficacy and Safety Evaluation of VS-101 in Combination With Chemoradiotherapy in Patients With Head and Neck CancerPhase 25 mi
Leveraging the Emergency Department (LEAD) StudyN/A6 mi
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.Phase 28 mi
Microbiotic Product to Promote Microbiome Health and Improve Chemotherapy DeliveryPhase 29 mi
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)Phase 29 mi
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)Phase 29 mi
Tirzepatide for Weight Loss Intervention in Early-Stage Hormone Receptor Positive/HER2 Negative Breast CancerPhase 29 mi
Optimize Neoadjuvant Therapy in HER2-Positive Early-Stage Breast CancerPhase 29 mi
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitean-hziy Versus Standard of Care in the Treatment of Advanced Urothelial CancerPhase 39 mi
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck CancerPhase 19 mi
Exercise to Improve Brain Health in Older African AmericansPhase 29 mi
Clinical Study of SNK01 in Participants With Moderate Alzheimer's DiseasePhase 1/29 mi
CCM OPEN HF Registry—9 mi
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskPhase 39 mi
Gait Adaptation StudyEarly 19 mi
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast CancersN/A9 mi
Liver Transplantation in Intrahepatic Cholangiocarcinoma—9 mi
DBS for DepressionPhase 19 mi
A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)Phase 29 mi
Dynamic Critical Congenital Heart Screening With Addition of Perfusion MeasurementsN/A9 mi
DBS for Obsessive-Compulsive DisorderN/A9 mi
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric ParticipantsPhase 29 mi
Pivotal Trial of Automated Artificial Intelligence (AI) Based System for Early Diagnosis of Diabetic Retinopathy—9 mi
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7Phase 2/39 mi
RADIANT: Pre-op Radiation With Abemaciclib and LetrozolePhase 19 mi
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology—9 mi
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)Phase 39 mi
Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer—10 mi
Phase 3 Pivotal Trial Comparing CARTISTEM® and Surgical Comparator for Knee Cartilage Lesions and OsteoarthritisPhase 311 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic PhenotypePhase 311 mi
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics—11 mi
A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)Phase 311 mi
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)Phase 311 mi
Mosaic Trial for Stem Cell Transplant RecipientsN/A11 mi
A Postmarketing Study of LEQEMBI in South Korean Participants With Alzheimer's Disease—11 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung CancerPhase 311 mi
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)Phase 311 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)Phase 312 mi
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)N/A12 mi
Evaluating the Impact of Social and Genetic Factors on Outcomes in Adolescent and Young Adult Cancer Survivors—12 mi
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer—12 mi
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE TrialPhase 312 mi
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT—12 mi
Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid TumorsPhase 112 mi
Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerPhase 212 mi
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 212 mi
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted TherapyPhase 2/312 mi
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)Phase 212 mi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)Phase 2/312 mi
Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003)Phase 312 mi
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary BlastomaPhase 312 mi
A Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)Phase 312 mi
Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung CancerPhase 212 mi
Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular CarcinomaPhase 212 mi
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerPhase 312 mi
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))N/A12 mi
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPhase 2/312 mi
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)N/A12 mi
Abbott Cephea Mitral Valve Disease Registry—12 mi
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)N/A12 mi
Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available Immunotherapy—12 mi
Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patients With Head and Neck CancerPhase 212 mi
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastatic Solid TumorsPhase 112 mi
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With SarcomaPhase 1/212 mi
Treatment of Radiation and Cisplatin Induced Toxicities with TempolPhase 212 mi
A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial CancerPhase 312 mi
Use of a Comprehensive, Mobile Application to Assist Cancer Patients With Diet, Nutrition and ActivityN/A12 mi
Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AMLPhase 212 mi
Chimeric Antigen Receptor T Cell Therapy Redirected to CD4 (CD4CAR)as a Second Line Treatment for Chronic Myelomonocytic Leukemia, CMML.Phase 112 mi
First In Human Study of CX-2051 in Advanced Solid TumorsPhase 112 mi
A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell CarcinomaPhase 112 mi
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment DelaysN/A12 mi
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid TumorsPhase 112 mi
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal CancerPhase 112 mi
Danvatirsen Monotherapy Followed by Combination With Venetoclax in Relapsed/Refractory MDS & AMLPhase 112 mi
Phase 1 Study of ACR-2316 in Specific Advanced Solid TumorsPhase 112 mi
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate CancerPhase 412 mi
Upfront Surgical Resection for Osteosarcoma—12 mi
ZZ06 in Adult Patients With Advanced Solid Tumor MalignanciesPhase 112 mi
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN LossPhase 212 mi
Reduced Intensity Haploidentical BMT for High Risk Solid TumorsPhase 212 mi
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic LeukemiaPhase 312 mi
FHD-286 With Low-Dose Weekly Decitabine/Venetoclax in Patients With Acute Myeloid LeukemiaPhase 112 mi
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA ResponsePhase 312 mi
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate CancerPhase 212 mi
A Study to Learn How PF-06821497 (Mevrometostat) Works in Men With Metastatic Castration-resistant Prostate Cancer.Phase 312 mi
Quality of End-of-Life Care for Children With Cancer—12 mi
Phase I/II Study of the Combination of Blinatumomab and Asciminib in Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaPhase 1/212 mi
A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder CancerPhase 112 mi
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)Phase 112 mi
A Study of JNJ-1761981 in Participants With Solid TumorsPhase 112 mi
Venetoclax Plus Intensive Chemotherapy in AML and Advanced MDSPhase 112 mi
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsPhase 212 mi
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2Phase 112 mi
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian CancerPhase 312 mi
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve OutcomesPhase 112 mi
Digoxin Medulloblastoma StudyPhase 212 mi
PVX4 for the Treatment of Human Papilloma Virus (HPV)16+ Cervical DysplasiaPhase 212 mi
Molecular and Genomic Profiling of Head and Neck Tumors—12 mi
DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or OsteosarcomaPhase 1/212 mi
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid LeukemiaPhase 312 mi
First in Human, Dose Escalation Study of AN4005Phase 112 mi
INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)Phase 312 mi
Hybrid Closed Loop Effectiveness Trial in Adults With Type 1 DiabetesN/A12 mi
Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney DiseasePhase 212 mi
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 DiabetesPhase 312 mi
Regulation of Endogenous Glucose Production by Central KATP ChannelsPhase 212 mi
Milk for Diabetes PreventionN/A12 mi
SPARK-CGM ImplementationN/A12 mi
Fresh Takes!: An Evaluation of the Impact of Receiving Fresh Food BoxesN/A12 mi
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background DapagliflozinPhase 312 mi
Orexin Antagonism for Suicide Risk: A Proof-of-Concept Clinical TrialPhase 212 mi
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 312 mi
Suicide Specific Rumination in VeteransN/A12 mi
Psilocybin to Treat Depression in Spinal Cord InjuryPhase 1/212 mi
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young AdultsN/A12 mi
ACP-204 in Adults With Alzheimer's Disease PsychosisPhase 2/312 mi
Cardiovascular Multimodality Imaging Study—12 mi
A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter SystemN/A12 mi
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava IsolationN/A12 mi
Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)—12 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney DiseasePhase 312 mi
ASTHMAXcel Voice StudyN/A12 mi
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With AsthmaPhase 312 mi
AeviceMD for Detection of Wheeze in Pediatric and Adult Populations—12 mi
Promoting Asthma Management Guidelines With Technology-Based Intervention and Care Coordination in Clinics and SchoolsN/A12 mi
Psychiatric Outcomes of Unruptured Intracranial Aneurysms (POUIA)N/A12 mi
Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and DepressionN/A12 mi
Transforming Care for Individuals With Childhood-onset Systemic Lupus ErythematosusN/A12 mi
Improving Adolescent and Young Adult Self-Reported Data in ECOG-ACRIN TrialsN/A12 mi
Intra-Operative Radiation Registry—12 mi
Reiki Breast Surgery QOL Project for Women Undergoing Breast SurgeryN/A12 mi
Circulating Tumor DNAPhase 212 mi
Desloratadine to Prevent Taxane-induced Peripheral Neuropathy in Patients With Breast CancerPhase 212 mi
TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast CancerN/A12 mi
TReatment of ADC-Refractory Breast CancEr With Dato-DXd or T-DXd: TRADE DXdPhase 212 mi
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Patients w/ NSCLCPhase 212 mi
Cough Capture as a Portal Into the Lung—12 mi
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)Phase 312 mi
EXoPERT EMERALD Clinical Study—12 mi
Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung CancerPhase 212 mi
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced CancersPhase 1/212 mi
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT TrialPhase 312 mi
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After TreatmentPhase 212 mi
Study of XB010 in Subjects With Solid TumorsPhase 112 mi
Centralized Screening Unit (CSU) at Montefiore-EinsteinN/A12 mi
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary CholangitisPhase 212 mi
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIVPhase 1/212 mi
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCCPhase 1/212 mi
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine TumorsPhase 212 mi
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCCPhase 212 mi
HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver CancerN/A12 mi
Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme MalignanciesPhase 212 mi
Study to Evaluate the Usability and Value of Integrated Digital Solutions in Medical Care of Participants With Multiple Sclerosis—12 mi
Immune Profile Selection By Fraction of ctDNA in Patients With Advanced NSCLC Treated With ImmunotherapyPhase 212 mi
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]Phase 312 mi
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)Phase 212 mi
First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate CancerPhase 1/212 mi
Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerPhase 2/312 mi
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Phase 312 mi
AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe EpilepsyPhase 1/212 mi
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)Phase 312 mi
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)—12 mi
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung CancerPhase 212 mi
Shield Post-Approval Study Protocol—12 mi
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)Phase 312 mi
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.Phase 312 mi
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment—12 mi
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid TumorsPhase 1/212 mi
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)Phase 1/212 mi
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE TrialPhase 312 mi
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid TumorsPhase 1/212 mi
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)Phase 312 mi
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)Phase 212 mi
Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naïve Participants With Advanced Or Metastatic Merkel Cell CarcinomaPhase 2/312 mi
Pediatric Precision Laboratory Advanced Neuroblastoma TherapyPhase 212 mi
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome—12 mi
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)Phase 212 mi
Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical ProstatectomyPhase 212 mi
The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALLPhase 212 mi
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)Phase 1/212 mi
XTX301 in Patients With Advanced Solid TumorsPhase 1/212 mi
A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon, Rectum, Stomach, or PancreasPhase 112 mi
ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer Rosettes—12 mi
A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid TumorsPhase 1/212 mi
Phase IB/II of CPX-351 for Relapse Prevention in AMLPhase 1/212 mi
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed MedulloblastomaPhase 212 mi
Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's LymphomaPhase 112 mi
Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic MalignanciesPhase 112 mi
Pembrolizumab and Lenvatinib in Advanced Cervical CancerPhase 212 mi
A First-in-Human Study of BG-C0979 in Adults With Advanced Solid TumorsPhase 112 mi
A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial TumorsPhase 212 mi
A Study of BG-C477 in Participants With Advanced Solid TumorsPhase 112 mi
A Study to Test How Different Doses of BI 1703880 in Combination With Ezabenlimab Are Tolerated in People With Different Types of Advanced Cancer (Solid Tumours)Phase 112 mi
Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid TumorsPhase 1/212 mi
A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has SpreadPhase 112 mi
A Phase 3 Study to Evaluate Petosemtamab Plus Pembrolizumab vs Pembrolizumab in First-line Treatment of Head and Neck Cancer (LiGeR - HN1)Phase 312 mi
Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple MyelomaPhase 112 mi
PUL-042 Treatment in Patients With Parainfluenza Virus (PIV), Human Metapneumovirus (hMPV) or Respiratory Syncytial Virus (RSV)Phase 212 mi
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell TherapyPhase 312 mi
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid TumorsPhase 112 mi
A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian CancersPhase 112 mi
Embryonal Tumor With Multilayered RosettesPhase 212 mi
Utility of 18F-rhPSMA-7.3 in the Diagnosis of Prostate Cancer After Focal Gland TreatmentN/A12 mi
A Global Study of the PETAL Consortium—12 mi
Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1Phase 112 mi
A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Mezigdomide in Combination With Elranatamab in Participants With Relapsed and/or Refractory Multiple MyelomaPhase 1/212 mi
Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerPhase 1/212 mi
OBWELL: Innovative Psychotherapeutic Intervention to Treat Postpartum DepressionN/A12 mi
Pulsed Electromagnetic Field Treatment In Patients With Alzheimer's DiseaseN/A12 mi
The HEARTFELT StudyN/A12 mi
A Study About How Blood Cell Growth Patterns Relate to Heart Health After Treatment for Hodgkin Lymphoma—12 mi
Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic ArthritisPhase 312 mi
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerPhase 312 mi
RAGE Inhibition to Decrease Cardiotoxicity in Women With Early Breast CancerPhase 1/212 mi
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.Phase 312 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.Phase 112 mi
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid TumorsPhase 112 mi
Support for Cancer Patients Awaiting NewsN/A12 mi
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant TumorsPhase 112 mi
Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic SarcomaPhase 212 mi
A Study of ZL-1310 in Subjects With Small Cell Lung CancerPhase 112 mi
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)Phase 112 mi
RAPA-201 Therapy of Solid TumorsPhase 1/212 mi
A Study With NKT3964 for Adults With Advanced/Metastatic Solid TumorsPhase 112 mi
CT-95 in Advanced Cancers Associated With Mesothelin ExpressionPhase 112 mi
A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid TumorsPhase 1/212 mi
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid TumorsPhase 1/212 mi
Post-operative Urinary Retention (POUR) Following Thoracic SurgeryPhase 1/212 mi
A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003)Phase 1/212 mi
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid TumorsPhase 1/212 mi
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular LymphomaPhase 112 mi
A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab Deruxtecan (I-DXd) in Participants With Relapsed/Refractory Extensive-Stage Small Cell Lung Cancer (MK-6070-002)Phase 1/212 mi
A Study of BMS-986490 With or Without Bevacizumab in Advanced Solid TumorsPhase 1/212 mi
A Phase 1 Study of LNCB74 in Advanced Solid TumorsPhase 112 mi
Evaluating Novel Therapies in ctDNA Positive GI CancersPhase 312 mi
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid TumoursPhase 1/212 mi
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)Phase 313 mi
Testing RG1-VLP Vaccine to Prevent HPV-related CancersPhase 113 mi
Registry for Stage 2 Type 1 Diabetes—13 mi
Study of ALTO-300 in MDDPhase 213 mi
Open-label Extension Study in Participants With Early Alzheimer's DiseasePhase 213 mi
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's DiseasePhase 213 mi
Trial-Ready Cohort-Down Syndrome (TRC-DS)—13 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe AsthmaPhase 313 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)Phase 313 mi
Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer SurvivorsN/A13 mi
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE TrialPhase 313 mi
Ultralow Dose PET Imaging of SSTR2 Radiotracer UptakePhase 213 mi
Ultralow Dose PET Imaging for PSMA ExpressionPhase 213 mi
Ultralow Dose PET Imaging of 18F-FDG UptakePhase 213 mi
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-—13 mi
Ultralow Dose PET Imaging of 18F-Florbetapir, 18F-FlutemetamolPhase 213 mi
Ultralow Dose PET Imaging for 18F-NaF UptakePhase 213 mi
Tempus Small Cell Lung Cancer Observational Study (Sculptor)—13 mi
Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial HepatectomyN/A13 mi
Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple SclerosisPhase 313 mi
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other TherapiesPhase 213 mi
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial CancerPhase 313 mi
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirvetuximab Soravtansine in Participants With Recurrent Ovarian Cancer With High Folate Receptor-Alpha ExpressionPhase 213 mi
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.Phase 313 mi
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple SclerosisPhase 313 mi
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) TrialN/A13 mi
Brain Activity Changes After Cognitive Behavioral Therapy for Anxiety in Autistic Youth From High-Need CommunitiesN/A13 mi
Focused Extracorporeal Shockwave Therapy for Knee ArthritisN/A14 mi
Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MSN/A14 mi
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene BesadenovecPhase 214 mi
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and DiabetesPhase 314 mi
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)Phase 316 mi
Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic AdenocarcinomaPhase 216 mi
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal CancerPhase 316 mi
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid TumorsPhase 116 mi
A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCCPhase 116 mi
DBC-664 in Adult Patients With Solid Tumors AssociatedPhase 116 mi
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry—16 mi
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)Phase 316 mi
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver MetastasisEarly 116 mi
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)N/A16 mi
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal CancerPhase 2/316 mi
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood TransfusionsPhase 316 mi
A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid TumorsPhase 116 mi
Study of NTB-928 in R/R OCPhase 116 mi
Trial to Evaluate the Safety and Preliminary Efficacy of GEN1079 in Participants With Advanced Solid TumorsPhase 116 mi
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of DiseasePhase 216 mi
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)Phase 116 mi
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid TumorsPhase 1/216 mi
Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk CohortN/A16 mi
A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyPhase 1/216 mi
The ME&MG Digital Solution for Autonomous Assessment of Myasthenia GravisN/A16 mi
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade GliomaPhase 1/216 mi
A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)Phase 116 mi
A Study of GEN1106 in Participants With Solid TumorsPhase 116 mi
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)Phase 316 mi
Adjuvant Tebentafusp in High Risk Ocular MelanomaPhase 316 mi
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)Phase 216 mi
STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected SarcomasPhase 1/216 mi
Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S TrialPhase 316 mi
Trial to Evaluate the Safety and Effectiveness of Treatment With COMS One Device in Subjects With Diabetic Foot UlcersN/A16 mi
DFC 004 Biomarkers for Active Diabetic Foot Ulcers—16 mi
Trial Investigating the Efficacy and Safety of Weekly Lonapegsomatropin Compared to Daily Somatropin in Children and Adolescents With Short Stature or Growth Failure Due to Growth Hormone Sufficient DisordersPhase 316 mi
A Long-term Treatment Extension Study of Niraparib in Participants Who Completed a Prior GlaxoSmithKline/TESARO-sponsored Niraparib StudyPhase 216 mi
Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid TumorsPhase 1/216 mi
Study of the Kinesin Oral Molecular Degrader BBI-940 in Subjects With Advanced or Metastatic Breast CancerPhase 116 mi
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid TumorsPhase 1/216 mi
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors TypesPhase 116 mi
IPH5201 and Durvalumab in Patients With Resectable Non-Small Cell Lung Cancer (MATISSE)Phase 216 mi
A Phase 1 Study of the Safety and Tolerability of CTX-10726Phase 116 mi
A Study of MGC026 in Participants With Advanced Solid TumorsPhase 116 mi
INFINITIVE: ImmuNotherapy For PatIeNts wIth colorecTal LIVer MEtastasesEarly 116 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid ArthritisPhase 216 mi
Perioperative Anticoagulant Use for Surgery Evaluation -Virtual Visit (PAUSE-Virtual)—16 mi
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry—16 mi
Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive DisorderPhase 216 mi
ALTO-207 in Adults With Treatment-resistant Depression (TRD)Phase 216 mi
Assessing the Fertility Status of Men With Spinal Muscular Atrophy (SMA)—16 mi
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseasePhase 316 mi
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).Phase 316 mi
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung CancerPhase 2/316 mi
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)Phase 316 mi
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic CancerPhase 116 mi
A Study of Intismeran Autogene (V940)/Placebo + Pembrolizumab and Chemotherapy in Metastatic Squamous Non-Small Cell Lung Cancer (V940-013)Phase 216 mi
Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on OsimertinibPhase 1/216 mi
A Study to Evaluate the Drug Levels, Efficacy, and Safety of Deucravacitinib (BMS-986165) in Pediatric Participants With Juvenile Psoriatic ArthritisPhase 317 mi
Maturation of Arteriovenous Fistula With Automated Sonography Assessments TrialN/A17 mi
A Study to Evaluate Solrikitug in Participants With COPD (ZION)Phase 217 mi
Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic CancerEarly 117 mi
First in Human Phase1/2a Clinical Trial of Anti-PAUF Monoclonal Antibody PBP1510 in Patients With Pancreatic CancerPhase 1/217 mi
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal SamplesN/A17 mi
Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)Phase 117 mi
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal AdenocarcinomaN/A17 mi
Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal MelanomaPhase 217 mi
Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)—17 mi
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)Phase 317 mi
Implanted Loop Recorders for Detection and Management of Arrhythmia With Bruton Tyrosine Kinase InhibitorsN/A17 mi
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)—17 mi
Optimal Ventilation for Cardiac ArrestN/A17 mi
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)Phase 317 mi
Virtual Personalized Exercise Program for Lung Cancer PatientsN/A17 mi
Renal Denervation + PVI vs PVI Alone for Persistent AFN/A17 mi
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management—17 mi
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs—17 mi
Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) StudyN/A17 mi
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)Phase 1/217 mi
CONVIVO EndomicroscopyN/A17 mi
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal CancerPhase 217 mi
Tau Networks in Psychotic Alzheimer&#39;s Disease—17 mi
Factor VIII Inhibitor Bypass Activity (FEIBA) Versus Fresh Frozen Plasma As First Line Therapy For Bleeding After Cardiac SurgeryPhase 217 mi
Clinical Study of the inQB8 TTVR System (The MonarQ Study)N/A17 mi
Trans-arterial Embolization for the Treatment of Facet Pain Due to Facet ArthropathyN/A17 mi
Trial of Belimumab in Early LupusPhase 417 mi
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment—17 mi
National Liver Cancer Screening TrialPhase 417 mi
Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot UlcersPhase 1/217 mi
Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone MetasPhase 217 mi
Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular LymphomaPhase 317 mi
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic FistulaPhase 317 mi
Investigating Targetable Metabolic Pathways Sustaining Pancreatic CancerN/A17 mi
mHealth Mindfulness With Patients With Serious Illness and Their CaregiversN/A17 mi
Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-TPhase 218 mi
Transcranial Direct Current Stimulation for DepressionN/A18 mi
An Internet-based Program to Help Cancer Survivors Manage PainN/A19 mi
Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast CancerPhase 319 mi
Collection of Sputum and Labeling for Lung Cancer—19 mi
Measuring Surgical Recovery After Radical Cystectomy—19 mi
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital DischargeN/A19 mi
First in Human Study of BAY2927088 in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations in the Genes of Epidermal Growth Factor Receptor (EGFR) and/or Human Epidermal Growth Factor Receptor 2 (HER2)Phase 1/219 mi
A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)Phase 220 mi
Detection and Risk Stratification in Veterans Presenting With Microscopic Hematuria—20 mi
Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainPhase 220 mi
Virtue® SAB in the Treatment of Coronary ISR TrialN/A20 mi
The Multicenter Stress Cardiac Magnetic Resonance Quantitative Perfusion Imaging in the United States StudyN/A20 mi
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure PatientsPhase 320 mi
A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients—20 mi
Testing the Feasibility of Computer-based Cognitive Training in Individuals with Multiple Sclerosis Living in the CommunityN/A20 mi
A Novel Combinatory Approach to Maximize Functional Recovery of Learning and Memory in Multiple SclerosisN/A20 mi
LRG GIST Patient Registry—20 mi
Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic CancerPhase 221 mi
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic DiseasePhase 321 mi
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLCPhase 321 mi
FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal CancerPhase 221 mi
A Study to Customize Ibrutinib Treatment Regimens for Participants With Previously Untreated Chronic Lymphocytic LeukemiaPhase 221 mi
A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell MalignanciesPhase 221 mi
Confirmatory Clinical Evaluation of Novilase® Laser Therapy for Focal Destruction of Malignant Breast TumorsN/A21 mi
Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies—21 mi
A Study of DB-1310 in Advanced/Metastatic Solid TumorsPhase 1/221 mi
A Study of Enasidenib in People With T-Cell LymphomaPhase 222 mi
Effects Of Osteopathic Manipulative Medicine(OMM) On Lower Extremity Muscle Characteristics In Parkinson's Disease(PD) PatientsN/A22 mi
Effects of Osteopathic Manipulative Treatment Protocol on Sleep Quality in Parkinson's Disease SubjectsN/A22 mi
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell LymphomaPhase 322 mi
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast CancerPhase 222 mi
A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone LymphomaPhase 322 mi
Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ICP-248 as Monotherapy or in Combination With Anti-CD20 Monoclonal Antibody in Mature B-cell MalignanciesPhase 122 mi
AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin LymphomaPhase 122 mi
An Open-label, Single-arm Study of Prophylaxis for Datopotamab Deruxtecan (Dato-DXd) -Related Stomatitis in Eligible Patients With Metastatic or Inoperable Locally Recurrent Breast Cancer or Locally Advanced or Metastatic Epidermal Growth Factor Receptor-Mutated Non-small Cell Lung Cancer.Phase 422 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)Phase 322 mi
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung CancerPhase 322 mi
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLCPhase 322 mi
A Study to Learn About Heart-Related Risks in Elderly Men With Advanced Prostate Cancer Treated With Enzalutamide or Darolutamide—23 mi
Neural and Psychiatric Consequences of Cannabis Use in AdolescentsN/A23 mi
The Effects of Daily Polyvagal Exercises on Stress in Students of Physical TherapyN/A23 mi
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe AsthmaPhase 225 mi
The Impact of CAR-T Cell Therapy on Fertility; A Patient Survey—25 mi
Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid TumorsPhase 1/225 mi
Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)N/A25 mi
A Study to Compare Setidegrasib (ASP3082) With Docetaxel, in People With Non-small Cell Lung Cancer With a KRAS G12D MutationPhase 325 mi
Exercise and Intranasal Insulin in Type 2 DiabetesPhase 2/325 mi
A Study of JNJ-95804306 for Relapsed or Refractory Hematological MalignanciesPhase 125 mi
Rutgers University Study of the Genetics of Pulmonary Hypertension—25 mi
Rutgers University Study of the Genetics of Breast Cancer.—25 mi
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)Phase 226 mi
Study of NALIRIFOX in Advanced Unresectable Small Bowel TumorsPhase 226 mi
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)Phase 2/326 mi
Use of CA125 and Complementary Biomarkers for the Early Detection of Ovarian Cancer in Low Risk WomenN/A26 mi
Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid TumorsPhase 126 mi
Pancreatic Cancer Detection Consortium—26 mi
Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)Phase 226 mi
A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate CancerPhase 126 mi
Highly Selective CDK7 Inhibitor Q901 in Selected Advanced Solid TumorsPhase 1/226 mi
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AMLPhase 2/326 mi
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR—26 mi
Assessing the Relationship Between Symptoms and Mitral Regurgitnant. Severity—26 mi
Silodosin for Urinary Symptoms in Female Patients With Multiple SclerosisPhase 426 mi
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)Phase 326 mi
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic CancerPhase 1/226 mi
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)Phase 326 mi
A Primary Care-Based Psychosocial Intervention To Improve Cognitive & Depression Outcomes in Older Adults With MCI & Early Stage ADN/A26 mi
Mind-Body Skills Group for Graduate StudentsN/A26 mi
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)Phase 326 mi
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)Phase 326 mi
Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 ChangePhase 226 mi
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)Phase 226 mi
Observational Study Protocol: LIVER-R—26 mi
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung CancerPhase 327 mi
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.Phase 327 mi
The Leukemia and Lymphoma Society (LLS) National Research Registry—27 mi
Clinical Utility of WATS3D: A 5-Year Prospective Study—28 mi
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)Phase 1/228 mi
Long-Term Outcomes of Teplizumab in Routine Clinical Care—28 mi
CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW PopulationsN/A28 mi
Stronger Together Psoriatic Arthritis Wellness Study—28 mi
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of CarePhase 328 mi
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 DiabetesPhase 328 mi
A Study to Evaluate the Safety and Pharmacokinetics of Eflapegrastim in Pediatric Participants With Solid Tumors or Lymphomas and Treated With Myelosuppressive ChemotherapyPhase 228 mi
Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS MalignanciesPhase 128 mi
Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHLPhase 228 mi
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)Phase 128 mi
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)Phase 1/228 mi
Autologous Stem Cell Transplant Followed by Polatuzumab Vedotin in Patients With B-cell Non-Hodgkin and Hodgkin LymphomaPhase 1/228 mi
AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell DepletionPhase 228 mi
Chemoimmunotherapy for ALK+ Relapsed/Refractory ALCLPhase 228 mi
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/LymphomaEarly 128 mi
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid TumorsPhase 128 mi
EBV-specific Cytotoxic T-lymphocytes (CTLs) for Refractory EBV InfectionPhase 228 mi
Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF StudyN/A28 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.Phase 328 mi
Behavioral Exposure for Introceptive Tolerance RCTN/A28 mi
Study Evaluating UCART20x22 in B-Cell Non-Hodgkin LymphomaPhase 1/228 mi
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)Phase 328 mi
SeqUential GeMcitabine and MITomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial CarcinomaPhase 228 mi
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck CancerPhase 1/228 mi
Loratadine for the Reduction of G-CSF Induced Bone Pain in Patients With Multiple Myeloma Undergoing Stem Cell MobilizationEarly 128 mi
A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell LymphomaPhase 328 mi
Adaptive Daily MR-Guided Adjuvant Pelvic Therapy-Endometrial CancerN/A28 mi
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)Phase 228 mi
Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer SurvivorsN/A28 mi
The Ailliance Post-Market Clinical StudyN/A28 mi
MySmartSkin Online Skin Self-exam Intervention for Melanoma SurvivorsN/A28 mi
Spine Oncology Registry—28 mi
Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal CancerPhase 228 mi
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)Phase 128 mi
A Mobile Health Intervention Among HispanicsN/A28 mi
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)Phase 128 mi
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.Phase 228 mi
Bright Ideas - CIN Feasibility StudyN/A28 mi
Addressing Genomic Disparities in Cancer SurvivorsN/A28 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid TumorsPhase 128 mi
Sun Safe Together: A Digital Skin Cancer Prevention Intervention for Adolescents and Their ParentsN/A28 mi
A Study of XB371 Administered in Participants With Locally Advanced or Metastatic Solid TumorsPhase 128 mi
Project CARE: CAncer Risk EvaluationN/A28 mi
E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated CancersPhase 1/228 mi
Effects of Latin Dancing on Sleep Quality in Hispanic Cancer SurvivorsN/A28 mi
A Youth-led Intervention to Reduce Healthcare Disparities in Cancer ScreeningN/A28 mi
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell CarcinomaPhase 328 mi
SynKIR-310 for Relapsed/Refractory B-NHLPhase 128 mi
Reducing Urban Cervical Cancer DisparitiesN/A28 mi
Naltrexone and Propranolol Combined With ImmunotherapyPhase 128 mi
Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular LymphomaPhase 228 mi
Exploration of Novel AI-enabled Blue Light Enhanced Cystoscopy—28 mi
To Evaluate Efficacy of Belinostat or Pralatrexate in Combination Against CHOP Alone in PTCLPhase 328 mi
Mosunetuzumab With Lenalidomide Augmentation as First-line Therapy for Follicular and Marginal Zone LymphomaPhase 228 mi
Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A)Phase 1/228 mi
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With REGN5678 for Adult Participants With Advanced Prostate CancerPhase 1/228 mi
A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid TumorsPhase 128 mi
Safety and Tolerability Study of GIM-122 in Subjects With Advanced Solid MalignanciesPhase 1/228 mi
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated CancersPhase 228 mi
MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial—28 mi
Extracellular Vesicles, Insulin Action, and ExerciseN/A28 mi
Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II DiabetesN/A28 mi
Virtual Diabetes Care for Adults With Type 2 Diabetes on Medicaid and Insulin TherapyN/A28 mi
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic PatientsN/A28 mi
ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older AdultsPhase 228 mi
Metabolic Health, Bones and Nuts During Weight Loss in AdultsN/A28 mi
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting—28 mi
The Salt Study for Heart FailureN/A28 mi
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)Phase 1/228 mi
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast CancerN/A28 mi
Investigating the Metabolic Pathways in Hormone Receptor Positive/HER2 Negative Breast CancerN/A28 mi
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast CancerPhase 1/228 mi
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung CancerPhase 128 mi
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy—28 mi
TELEhealth Shared Decision-making COaching for Lung Cancer Screening in Primary Care (TELESCOPE) for HispanicsN/A28 mi
Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cmPhase 228 mi
TELESCOPE- TELEhealth Shared Decision-making COachingN/A28 mi
KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsPhase 128 mi
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac EventsPhase 229 mi
ENA-001 for Opioid Induced Respiratory DepressionPhase 129 mi
A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisPhase 229 mi
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in AdultsPhase 129 mi
Study of GS-2426 in Participants With Advanced Solid TumorsPhase 129 mi
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Colorectal CancerPhase 229 mi
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic CancerPhase 229 mi
A Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate CancerPhase 1/229 mi
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)Phase 229 mi
A Dose Escalation Study of AV-380 in Cancer Patients With CachexiaPhase 129 mi
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast CancerPhase 229 mi
ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsPhase 329 mi
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung CancerPhase 2/329 mi
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic AlterationsPhase 1/229 mi
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid TumorsPhase 1/229 mi
The CDK4/6 Inhibitor Dosing Knowledge (CDK) StudyPhase 329 mi
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersPhase 229 mi
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene MutationPhase 229 mi
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid CancerPhase 329 mi
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast CancerPhase 1/229 mi
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung CancerPhase 1/229 mi
Rectal Spacers Use in Prostate Cancer Radiation TherapyN/A29 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePhase 329 mi
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)Phase 329 mi
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP DeletionPhase 2/329 mi
PROton Therapy for Post Surgical Treatment of GYNecologic CancerPhase 230 mi
The Radiation Oncology Registry and Biosample Repository—30 mi
A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder CancerPhase 330 mi
Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III TrialPhase 330 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)Phase 330 mi
Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic TherapyN/A30 mi
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Randomized, Phase II Multi-center Trial Evaluating Shorter Schedules of Adjuvant Regional Nodal Irradiation Among Women and Men With Node-positive and High-risk Node-negative Invasive Breast CancerPhase 230 mi
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic AlterationsPhase 330 mi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)Phase 230 mi
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier—34 mi
A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy—34 mi
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS MutationsPhase 334 mi
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCLPhase 234 mi
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or OverweightPhase 234 mi
Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have DiabetesPhase 334 mi
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)Phase 234 mi
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's TypePhase 334 mi
STOP AF First Post-Approval Study—34 mi
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBCPhase 234 mi
Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialPhase 334 mi
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)Phase 334 mi
Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening—34 mi
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast CancerPhase 1/234 mi
A Phase IIb Ensifentrine-glycopyrrolate Fixed-dose Combination Dose Ranging Study in Subjects With COPDPhase 235 mi
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic PhenotypePhase 335 mi
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric CancerPhase 135 mi
A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With RavulizumabPhase 435 mi
Persona Revision Knee System Outcomes—37 mi
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial CancerPhase 2/337 mi
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced CancerN/A37 mi
Molecular Genetics Studies of Cancer Patients and Their Relatives—37 mi
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)Phase 337 mi
Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)Phase 337 mi
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseasePhase 237 mi
Clinical Utility of an Amniotic Membrane Allograft for Diabetic Foot Ulcer Wound ManagementN/A38 mi
External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy—38 mi
A Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate CancerPhase 1/238 mi
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2Phase 238 mi
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:—38 mi
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseasePhase 438 mi
Prospective Remapping With Concomitant Left Atrial Appendage Occlusion to Ensure Durable Electroporation StudyN/A40 mi
Caris Biorepository Research Protocol—40 mi
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)Phase 240 mi
Foundational Programs to Combat Clinician StressN/A41 mi
A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical TrialsN/A41 mi
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C MutationPhase 342 mi
A Pancreatic Cancer Screening Study in Hereditary High Risk Individuals—42 mi
The Role of MicroRNA in the Diagnosis, Prognosis and Response to Treatment in Pancreatic Cancer—42 mi
A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus—42 mi
Practical Geriatric Assessment (PGA) Implementation Strategies and Correlative Evaluations (PACE-70)—43 mi
Phase 1 Study of CLR 125 in Triple Negative Breast CancerPhase 143 mi
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid TumorsPhase 1/243 mi
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)Phase 1/243 mi
Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)Phase 243 mi
Neurologic Stem Cell Treatment StudyN/A45 mi
International Weight Control Registry—47 mi
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)Phase 348 mi
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell LymphomaPhase 148 mi
Raman Spectroscopy and Skin Cancer—48 mi
Testing a Brief Motivational Intervention to Increase Physical Activity for Cancer SurvivorsN/A48 mi
Acute Myeloid Leukemia and Markers of Leukemia Stem Cells (CLL1 and CD45RA)—48 mi
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCTPhase 348 mi
A Trial to Learn How Well Linvoseltamab Works Compared to the Combination of Elotuzumab, Pomalidomide and Dexamethasone for Adult Participants With Relapsed/Refractory Multiple MyelomaPhase 348 mi
Atezolizumab and Pre-Surgical Brain Radiation Therapy for Glioblastoma MultiformeEarly 148 mi
Decision Aid and Thyroid Nodules ManagementN/A48 mi
Combination of Novel Therapies for CKD Comorbid DepressionPhase 248 mi
PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.Phase 448 mi
The Role of mGluR5 in CBT-IPhase 448 mi
Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFSN/A48 mi
The VENTOR Clinical StudyN/A48 mi
Randomized Placebo Controlled Study of Triamcinolone Acetonide Extended Release Injection for Thumb (CMC) OsteoarthritisPhase 248 mi
Impact of Art Therapy on Self-Reported Pain and Anxiety Scores of Patients Waiting to Be Seen in the Emergency DepartmentN/A48 mi
Fear and Anxiety in Anesthesia-Naïve Patients Pre-operatively vs Post-operatively—48 mi
Neoadjuvant Therapy and Contrast-enhanced Mammography for Early Stage Breast CancerEarly 148 mi
SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer SurvivorsN/A48 mi
Definitive Radiation Therapy for Inoperable Breast CancerN/A48 mi
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain MetastasesPhase 248 mi
CtDNA Based MRD Testing for NAC Monitoring in TNBC—48 mi
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)Phase 2/348 mi
Definitive Radiation for High-Risk Spine MetastasesPhase 248 mi
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM StudyPhase 249 mi
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VPhase 250 mi

Frequently Asked Questions

How many clinical trials are recruiting in New York?

There are currently 2,640 actively recruiting clinical trials in New York across 1 city.

Which cities in New York have the most clinical trials?

The top cities are New York (2640 trials).

What conditions are being studied in New York?

Researchers in New York are studying Alzheimer's Disease, Anxiety, Arthritis, Asthma, Breast Cancer, and 12 more conditions.

What trial phases are available in New York?

Available phases include Phase 2 (20%), NA (17%), Phase 3 (17%).

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.